Frequencies for first 10,000 rows of dose_vbm variable in drug2004q2 dataset : Verbatim text for dose, frequency, and | route, exactly as entered on report | Freq. Percent Cum. ----------------------------------------+----------------------------------- | 7,207 72.07 72.07 (3 IN 1 WEEK (S)) TOPICAL | 1 0.01 72.08 (DAILY) | 1 0.01 72.09 (DAILY), ORAL | 1 0.01 72.10 (DASILY), INTRAMUSCULAR | 1 0.01 72.11 -OPEN-LABEL | 1 0.01 72.12 .05 MG, TWICE WEEKLY | 1 0.01 72.13 .125MG PER DAY | 2 0.02 72.15 .25MG PER DAY | 1 0.01 72.16 .3MG TWICE PER DAY | 1 0.01 72.17 .5 ML, QD | 1 0.01 72.18 .5MG PER DAY | 2 0.02 72.20 .5MG TWICE PER DAY | 1 0.01 72.21 .9 MG, UNK | 1 0.01 72.22 0 MG ONCE A DAY ORAL | 1 0.01 72.23 0.067 MG/KG, QD, SUBCUTANEOUS | 1 0.01 72.24 0.067MG/KG, DAILY, SUBCUTAENOUS | 1 0.01 72.25 0.088 MG/DAY | 1 0.01 72.26 0.1 % TOP-DERM | 1 0.01 72.27 0.1 MG (DAILY), ORAL | 1 0.01 72.28 0.1 MG, PO | 1 0.01 72.29 0.1 ML (30MG/ML) SQ | 1 0.01 72.30 0.10 %, TOPICAL | 1 0.01 72.31 0.125 MG, ORAL | 1 0.01 72.32 0.125 MG/D | 1 0.01 72.33 0.125 MG/DAY, ORAL | 1 0.01 72.34 0.2 MG IT | 1 0.01 72.35 0.2 MG, QD, UNK | 1 0.01 72.36 0.2 MG, TOTAL DAILY, ORAL | 1 0.01 72.37 0.25 MG 1 X PER 1 DAY, ORAL | 1 0.01 72.38 0.25 MG, IN 1 DAY, ORAL | 1 0.01 72.39 0.25 MG, UNK, ORAL | 1 0.01 72.40 0.25MG, QD, INTRAVENOUS | 1 0.01 72.41 0.3-0.2MG/KG ORAL | 1 0.01 72.42 0.375MG, 0.375MG, ORAL | 1 0.01 72.43 0.4 MG (0.4MG, 1 KA O.D.) PO | 1 0.01 72.44 0.4 MG, QD | 1 0.01 72.45 0.4ML WEEKLY SUBCUTANEOUS | 1 0.01 72.46 0.5 DAILY | 1 0.01 72.47 0.5 MCI/INJECTION | 1 0.01 72.48 0.5 MG INTRAVENOUS DRIP | 1 0.01 72.49 0.5 MG BID | 1 0.01 72.50 0.5 MG BID PO | 1 0.01 72.51 0.5 MG QD PO | 1 0.01 72.52 0.5 MG, 1 IN 1 DAY, ORAL | 1 0.01 72.53 0.5 MG, 3 IN 1 DAY, ORAL | 1 0.01 72.54 0.5 MG/D | 1 0.01 72.55 0.5 ML | 1 0.01 72.56 0.5 TABLET 2 X PER 1 DAY, ORAL | 1 0.01 72.57 0.625 MG DAILY, ORAL : 1.25 MG, DAILY.. | 1 0.01 72.58 0.8 MG, QD, SUBCUTANEOUS | 1 0.01 72.59 0.8 ML WEEKLY SC | 1 0.01 72.60 0.8 UG/KG | 1 0.01 72.61 0.89 MG, DAY 1-5, IV | 1 0.01 72.62 0.9 MG (0.9 MG, 3 IN 1 D) | 1 0.01 72.63 1 AM DAY | 1 0.01 72.64 1 BID 150 MG | 1 0.01 72.65 1 CC, ONCE, SUBCUTANEOUS | 1 0.01 72.66 1 DAILY 5 DAYS | 1 0.01 72.67 1 DAY BUCCAL | 1 0.01 72.68 1 DF BID PO | 1 0.01 72.69 1 DF DAILY PO | 3 0.03 72.72 1 DF, BID | 1 0.01 72.73 1 DF, ONCE/SINGLE | 1 0.01 72.74 1 DF, QD | 8 0.08 72.82 1 DF, QW | 1 0.01 72.83 1 DF/D | 2 0.02 72.85 1 DOSE 2X PER 1 DAY , ORAL | 1 0.01 72.86 1 DOSE EACH NOSTRIL | 1 0.01 72.87 1 DOSE(S), 1 IN 1 DAY, ORAL | 1 0.01 72.88 1 DOSE(S), 3 IN 1 TOTAL, ORAL | 1 0.01 72.89 1 G BID ORAL | 1 0.01 72.90 1 G DAILY PO | 1 0.01 72.91 1 G, IN 1 DAY, ORAL | 1 0.01 72.92 1 G, TID | 1 0.01 72.93 1 G/D | 2 0.02 72.95 1 GM IV | 4 0.04 72.99 1 GM IVP USA QD | 1 0.01 73.00 1 GRAM, INTRAVENOUS | 1 0.01 73.01 1 IN 1 D, INJECTION | 2 0.02 73.03 1 IN 12 H, ORAL | 1 0.01 73.04 1 IN 2 WK, SUBCUTANEOUS | 1 0.01 73.05 1 IN 72 HOUR, TRANSDERMAL | 1 0.01 73.06 1 IU, ORAL | 1 0.01 73.07 1 MD TID PO | 1 0.01 73.08 1 MG | 1 0.01 73.09 1 MG (DAILY), ORAL | 1 0.01 73.10 1 MG DAILY PO | 1 0.01 73.11 1 MG LOCKOUT WITH 4HTR MAX. DELIVERY .. | 1 0.01 73.12 1 MG PO | 1 0.01 73.13 1 MG QD | 2 0.02 73.15 1 MG QD PO | 2 0.02 73.17 1 MG, 1 IN 1 DAY, ORAL | 1 0.01 73.18 1 MG, IN 1 DAY, ORAL | 1 0.01 73.19 1 MG, QD, ORAL | 2 0.02 73.21 1 MG, TID, PER ORAL | 1 0.01 73.22 1 MG, UNK | 2 0.02 73.24 1 MG/D | 1 0.01 73.25 1 MG/DAY, ORAL | 1 0.01 73.26 1 MG/KG, | 1 0.01 73.27 1 ML, BID, TOPICAL | 1 0.01 73.28 1 OR 2 1 OR 2 X D | 1 0.01 73.29 1 OR 2 TABS EVERY 4 HO ORAL | 1 0.01 73.30 1 OR TWICE DAILY OTHER | 1 0.01 73.31 1 PATCH | 1 0.01 73.32 1 PER DAY | 2 0.02 73.34 1 PER DAY ORAL | 2 0.02 73.36 1 PILL | 1 0.01 73.37 1 PILL EVERY MORN ORAL | 1 0.01 73.38 1 PRN | 1 0.01 73.39 1 PUFF TWICE /DAY ORAL | 1 0.01 73.40 1 QD | 2 0.02 73.42 1 SPR IN ONE NOSTRI Q6H | 1 0.01 73.43 1 SPRAY 2-4 HRS. | 1 0.01 73.44 1 SPRAY ALTERNATE NOSTRIL DAILY | 1 0.01 73.45 1 SPRAY; TWICE A DAY; NASAL | 1 0.01 73.46 1 T QD ORAL | 1 0.01 73.47 1 TAB AES#DOSE_FREQUENCY: DLY | 1 0.01 73.48 1 TAB PO BID | 1 0.01 73.49 1 TAB PRN THEN 1 TAB QD, ORAL | 1 0.01 73.50 1 TAB QD ORAL | 1 0.01 73.51 1 TABLET 2 X DAILY | 1 0.01 73.52 1 TABLET A DAY | 1 0.01 73.53 1 TABLET DAILY | 1 0.01 73.54 1 TABLET DAILY ORAL | 5 0.05 73.59 1 TABLET DAILY OTHER | 1 0.01 73.60 1 TABLET DAILY, ORAL | 1 0.01 73.61 1 TABLET DAY ORAL | 1 0.01 73.62 1 TABLET, ORAL | 1 0.01 73.63 1 TABLET, QD, ORAL | 1 0.01 73.64 1 TABLET/D | 1 0.01 73.65 1 TABLET/WEEK | 1 0.01 73.66 1 TSP 1X PER 4 HR, ORAL | 1 0.01 73.67 1 TSP 2/DAY ORAL | 1 0.01 73.68 1 TWICE DAILY | 1 0.01 73.69 1 UNK, BID | 1 0.01 73.70 1 UNK, QID | 1 0.01 73.71 1 X INTRADERMAL | 1 0.01 73.72 1-4 TABLETS QD | 1 0.01 73.73 1.0 MG/M2 | 1 0.01 73.74 1.0 MG/M2: | 1 0.01 73.75 1.25 MG DAILY : 5 MG, DAILY, ORAL : 2.. | 1 0.01 73.76 1.25 MG ONCE IV | 1 0.01 73.77 1.25 MG X 1 | 1 0.01 73.78 1.25MG PER DAY | 1 0.01 73.79 1.3 MG, 4 IN DAY | 1 0.01 73.80 1.4 MG, 3 IN 1 DAY, ORAL | 1 0.01 73.81 1.4 MG/M2 Q3W | 1 0.01 73.82 1.5 MG, IN 1 DAY, ORAL | 1 0.01 73.83 1.5 MG/M2 WEEKLY/1.5 MG/M2 MONTHLY | 1 0.01 73.84 1.5 MIU, BID X 5 DAYS Q 8 WKS, SUBCUT.. | 1 0.01 73.85 1.7 UG/KG | 2 0.02 73.87 1/2 BOTTLE @ 1H ESP, 1/2 BOTTLE @ 3 H.. | 1 0.01 73.88 1/2 PIPETTE DAILY | 1 0.01 73.89 1/2 TABLET EVERY 2 DAYS | 1 0.01 73.90 1/2 TABLET QD | 1 0.01 73.91 1/2 TABLET X 2 | 1 0.01 73.92 10 MG | 3 0.03 73.95 10 MG (DAILY) | 1 0.01 73.96 10 MG (DAILY), ORAL | 7 0.07 74.03 10 MG (DAILY), UKNOWN | 1 0.01 74.04 10 MG , ORAL | 1 0.01 74.05 10 MG / DAY | 3 0.03 74.08 10 MG 1X PER 1 DAY | 1 0.01 74.09 10 MG 1X PER 1 DAY; ORAL | 1 0.01 74.10 10 MG 3 TIMES DAILY | 1 0.01 74.11 10 MG AMLOD/20 MG BENAZ QD | 1 0.01 74.12 10 MG BID PO | 6 0.06 74.18 10 MG DAILY | 2 0.02 74.20 10 MG DAILY PO | 4 0.04 74.24 10 MG DAILY, ORAL | 1 0.01 74.25 10 MG EVERY NIGHT | 1 0.01 74.26 10 MG FREQ | 1 0.01 74.27 10 MG HS PO | 1 0.01 74.28 10 MG INTRAVENOUS | 1 0.01 74.29 10 MG PO | 2 0.02 74.31 10 MG PRN ORAL | 1 0.01 74.32 10 MG QAM PO | 2 0.02 74.34 10 MG QD | 2 0.02 74.36 10 MG QD ORAL | 1 0.01 74.37 10 MG QD PO | 18 0.18 74.55 10 MG QID ORAL | 1 0.01 74.56 10 MG WEEKLY | 1 0.01 74.57 10 MG WEEKLY PO | 1 0.01 74.58 10 MG, 4 IN 1 DAY | 1 0.01 74.59 10 MG, (DAY 0) | 1 0.01 74.60 10 MG, 1 IN 1 D, PER ORAL | 1 0.01 74.61 10 MG, 3 IN 1 DAY | 3 0.03 74.64 10 MG, 3 IN 1 DAY, | 1 0.01 74.65 10 MG, 4 IN 1 DAY, ORAL | 1 0.01 74.66 10 MG, 8 MG | 1 0.01 74.67 10 MG, BID | 2 0.02 74.69 10 MG, BID, ORAL | 2 0.02 74.71 10 MG, DAILY | 1 0.01 74.72 10 MG, DAILY, ORAL | 1 0.01 74.73 10 MG, ORAL | 1 0.01 74.74 10 MG, PO , 2-BID | 1 0.01 74.75 10 MG, Q12H, ORAL | 1 0.01 74.76 10 MG, QD | 3 0.03 74.79 10 MG, QD, ORAL | 3 0.03 74.82 10 MG, TID, | 1 0.01 74.83 10 MG, TOTAL DAILY, ORAL | 1 0.01 74.84 10 MG, UNK | 1 0.01 74.85 10 MG, WEEKLY, INTRAMUSCULAR | 1 0.01 74.86 10 MG/D | 2 0.02 74.88 10 MG/D PO | 1 0.01 74.89 10 MG/DAY | 4 0.04 74.93 10 MG/DAY ORAL | 1 0.01 74.94 10 MG/KG, Q2W, INTRAVENOUS | 1 0.01 74.95 10 MG; BID; PO | 1 0.01 74.96 10 MG; IN AM; PO | 1 0.01 74.97 10 MILLION IU, 1 DOSAGE FORM CYCLIC; SC | 2 0.02 74.99 10 ML ONCE ED | 1 0.01 75.00 10 MU INTRAMUSCULAR | 1 0.01 75.01 10 MU TIW INTRAMUSCULAR | 1 0.01 75.02 10 UG IT | 1 0.01 75.03 10 UG, INT CORP CAVERN | 1 0.01 75.04 10 UNITS 4:25, 10 UNITS 4:55 | 1 0.01 75.05 10 UNITS X2 30 MIN APART | 1 0.01 75.06 10, 000 U SQ X 1 | 2 0.02 75.08 10, 000 UNITS | 1 0.01 75.09 10-3 MU QD,TIW, INTRAMUSCLAR; 6 MU TI.. | 1 0.01 75.10 100 MCG (25 MCG, 2 PUFFS TWICE DAILY) | 1 0.01 75.11 100 MCG QWK SUBCUTANEOUS; 120 MCG SUB.. | 1 0.01 75.12 100 MG | 2 0.02 75.14 100 MG (DAILY), ORAL | 1 0.01 75.15 100 MG (PRN), ORAL | 1 0.01 75.16 100 MG (PRN), ORAL ONCE | 1 0.01 75.17 100 MG / DAY | 2 0.02 75.19 100 MG 1 X PER DA ORAL | 1 0.01 75.20 100 MG 2/D PO | 1 0.01 75.21 100 MG 2X PER 1 DAY; ORAL | 1 0.01 75.22 100 MG AES#DOSE_FREQUENCY: DLY | 1 0.01 75.23 100 MG BID ORAL | 1 0.01 75.24 100 MG BID PO | 2 0.02 75.26 100 MG DAILY | 1 0.01 75.27 100 MG DAILY ORAL | 4 0.04 75.31 100 MG DAILY PO | 1 0.01 75.32 100 MG DAILY, ORAL | 2 0.02 75.34 100 MG IV | 2 0.02 75.36 100 MG ONCE PO | 4 0.04 75.40 100 MG OVERDOSE | 1 0.01 75.41 100 MG PO QD | 1 0.01 75.42 100 MG QD FOR 4 DAYS | 1 0.01 75.43 100 MG QD PO | 2 0.02 75.45 100 MG QD, ORAL | 1 0.01 75.46 100 MG, 0.5 TAB DAILY | 1 0.01 75.47 100 MG, 1/WEEK, INTRAVENOUS | 3 0.03 75.50 100 MG, BID | 1 0.01 75.51 100 MG, BID, ORAL | 2 0.02 75.53 100 MG, DAILY FOR 14 DAYS, THEN OFF F.. | 1 0.01 75.54 100 MG, DAILY, ORAL | 3 0.03 75.57 100 MG, IN 1 DAY, ORAL | 2 0.02 75.59 100 MG, INTRAVENOUS | 2 0.02 75.61 100 MG, ORAL | 3 0.03 75.64 100 MG, QD | 2 0.02 75.66 100 MG, QD, ORAL | 3 0.03 75.69 100 MG, QHS, ORAL | 1 0.01 75.70 100 MG, TID, ORAL | 1 0.01 75.71 100 MG, UNK | 1 0.01 75.72 100 MG, X2, INTRAVENOUS | 1 0.01 75.73 100 MG/D | 1 0.01 75.74 100 MG/DAY | 1 0.01 75.75 100 MG/M2 DAYS 1-3 Q 3 WKS X 4 | 3 0.03 75.78 100 MG/M2 IV | 1 0.01 75.79 100 MG/M2 OTHER - INTRAVENOUS NOS | 1 0.01 75.80 100 ML, SINGLE DOSE, I.V. | 1 0.01 75.81 100 UG, UNK, SUBCUTANEOUS | 1 0.01 75.82 100 UG/D | 1 0.01 75.83 100 UG/DAY | 1 0.01 75.84 100 UG/HR, TRANSDERMAL | 2 0.02 75.86 100 UG; TIW; SUBCUTANEOUS | 3 0.03 75.89 100-200MG, DAILY, ORAL | 1 0.01 75.90 100-400 MG/DAY | 1 0.01 75.91 100-650MG QD ORAL | 1 0.01 75.92 1000 MCG (250 MCG, 2 PUFFS TWICE DAILY) | 1 0.01 75.93 1000 MG (BID), ORAL | 1 0.01 75.94 1000 MG PO | 1 0.01 75.95 1000 MG QD IV 2/23-2/27 THEN Q MON+TH.. | 1 0.01 75.96 1000 MG, ORAL | 1 0.01 75.97 1000 MG, PO | 1 0.01 75.98 1000 MG, TOTAL DAILY, ORAL | 1 0.01 75.99 1000 MG, X2, INTRAVENOUS | 1 0.01 76.00 1000 MG/DAY | 1 0.01 76.01 1000 MG/KG Q1HR | 1 0.01 76.02 1000 MG/M2 | 1 0.01 76.03 1000 MG/M2 DAY 1, 8 Q21 DAYS IV | 1 0.01 76.04 1000 UG, UNK, INT CORP CAVERN | 1 0.01 76.05 1000-1100MG, DAILY, ORAL | 1 0.01 76.06 1000IU PER DAY | 1 0.01 76.07 1000MG THREE TIMES PER DAY | 1 0.01 76.08 1000UNITS/HR | 1 0.01 76.09 100MCG INHALATION | 1 0.01 76.10 100MG IN THE MORNING | 1 0.01 76.11 100MG IV DAILY | 1 0.01 76.12 100MG PER DAY | 5 0.05 76.17 100MG QD, ORAL | 1 0.01 76.18 100MG THREE TIMES PER DAY | 1 0.01 76.19 100MG TID, ORAL | 1 0.01 76.20 100MG TWICE PER DAY | 4 0.04 76.24 100MG/DAY, ORAL | 1 0.01 76.25 100UG/DAY | 1 0.01 76.26 102 IU, QD, INTRAUTERINE | 1 0.01 76.27 103 MG IV DAY 1 | 1 0.01 76.28 104 MG, Q3W, INTRAVENOUS | 1 0.01 76.29 1040 MG, Q3W, INTRAVENOUS | 1 0.01 76.30 1050 MG IV | 1 0.01 76.31 109 MG Q 21 D IV | 1 0.01 76.32 10MG IN THE MORNING | 1 0.01 76.33 10MG PER DAY | 8 0.08 76.41 10MG QD ORAL | 2 0.02 76.43 10MG UNKNOWN | 2 0.02 76.45 10ML VARIABLE DOSE | 1 0.01 76.46 110 MG IV WEEKLY | 3 0.03 76.49 110MCG FOUR TIMES PER DAY | 1 0.01 76.50 110MCG PER DAY | 1 0.01 76.51 110MCG TWICE PER DAY | 9 0.09 76.60 110MCG UNKNOWN | 4 0.04 76.64 110MG TWICE PER DAY | 1 0.01 76.65 115 MG, 1 IN 1 DAY, INTRAVENOUS | 1 0.01 76.66 119 MG IV | 1 0.01 76.67 12 G DAILY | 1 0.01 76.68 12 GRAM (Q2H), INTRAVENOUS | 1 0.01 76.69 12 GY | 1 0.01 76.70 12 MG IT | 1 0.01 76.71 12 MG QD IV 2/23-2/27 EVERY HEMG Q MO.. | 1 0.01 76.72 12 MG, QD, ORAL; SEE IMAGE | 1 0.01 76.73 12 MIU INTRAMUSCULAR | 1 0.01 76.74 12.5 MG (UNSPECIFIED DOSE AND FREQUEN.. | 1 0.01 76.75 12.5 MG 1 X PER 1 WK , ORAL | 1 0.01 76.76 12.5 MG X 1, IV | 1 0.01 76.77 12.5 MG, WEEKLY, INTRAMUSCULAR | 1 0.01 76.78 12.5 PO | 1 0.01 76.79 12.5MG QD ORAL | 1 0.01 76.80 120 MCG QWK INTRAMUSCULA | 1 0.01 76.81 120 MG (BID), ORAL | 1 0.01 76.82 120 MG QD PO | 1 0.01 76.83 120 MG, TOTAL DAILY, ORAL | 1 0.01 76.84 120 MG, UNK | 1 0.01 76.85 120 MG/M2 GIVEN ON DAYS 1, 2 AND 3, I.. | 1 0.01 76.86 120 MG/M2 PER_CYCLE | 1 0.01 76.87 120 ML | 1 0.01 76.88 1200 MG (TID), ORAL | 1 0.01 76.89 1200 MG QD ORAL | 2 0.02 76.91 1200 MG, DAILY, ORAL | 1 0.01 76.92 120MCG TWICE PER DAY | 1 0.01 76.93 120MG PER DAY | 1 0.01 76.94 124 MG IV | 1 0.01 76.95 125 G, BID, INTRAVENOUS | 1 0.01 76.96 125 MG QAM, 187.5 MG QPM (SEE TEXT), PO | 1 0.01 76.97 125 MG QD ORAL | 1 0.01 76.98 125 MG, BID, ORAL | 1 0.01 76.99 125 MG, BID, ORAL; 62.5 MG, BID, ORAL | 1 0.01 77.00 125 MG, QD | 1 0.01 77.01 125 MG/D | 4 0.04 77.05 125 MG/M2, WEEKLY FOR FOUR WEEKS, INT.. | 2 0.02 77.07 125 MG/M2, WEKLY FOR FOUR WEEKS,INTRA.. | 1 0.01 77.08 125MG PER DAY | 1 0.01 77.09 125MG/DAY | 1 0.01 77.10 125U UNKNOWN | 1 0.01 77.11 127 MG D1 IV | 1 0.01 77.12 1288 MG PER DAY INTRAVENOUS | 1 0.01 77.13 12G PER DAY | 1 0.01 77.14 12TAB SINGLE DOSE | 1 0.01 77.15 13.5 GRAM (Q8H), INTRAVENOUS | 1 0.01 77.16 130 MG IN THE 24 HOURS PRIOR TO EVENT | 1 0.01 77.17 130 MG/M2 Q3W, INTRAVENOUS NOS | 1 0.01 77.18 1300 MGM PO BID | 1 0.01 77.19 1334 MG BID PO | 1 0.01 77.20 135 MG/M2, Q21 DAYS, CYCLIC, IV | 2 0.02 77.22 14 MG PER DAY IV | 1 0.01 77.23 14 MG/SINGLE DOSE/ TRANSDERMAL | 1 0.01 77.24 140 MG FREQ | 1 0.01 77.25 140 MG TID ORAL | 1 0.01 77.26 1400 MCG X 1 IV | 1 0.01 77.27 1400.0 MG; QD;PO | 1 0.01 77.28 140MG/M2 (DAY -2) | 1 0.01 77.29 140MG/M2 DAY -2 | 2 0.02 77.31 140MG/M2 DAY-2 | 1 0.01 77.32 15 MCG QW IM | 2 0.02 77.34 15 MG (15 MG, 1 D) PER ORAL | 1 0.01 77.35 15 MG (15 MG, 1 IN 1 D) | 2 0.02 77.37 15 MG (DAILY), ORAL | 2 0.02 77.39 15 MG 1 X PER 1 DAY, INTRAVENOUS | 1 0.01 77.40 15 MG 1X PER 1 DAY | 1 0.01 77.41 15 MG DAILY ORAL | 1 0.01 77.42 15 MG ONE PO Q AM | 1 0.01 77.43 15 MG PER CYCLE , IT | 1 0.01 77.44 15 MG PO Q HS | 1 0.01 77.45 15 MG QD PO | 6 0.06 77.51 15 MG QW IM | 6 0.06 77.57 15 MG, 1 IN 1 D, PER ORAL | 3 0.03 77.60 15 MG, 1 IN 1 WEEK, ORAL; 10 MG, 1 IN.. | 1 0.01 77.61 15 MG, 1IN 1 D, PER ORAL | 1 0.01 77.62 15 MG, BID, ORAL | 1 0.01 77.63 15 MG, QD | 1 0.01 77.64 15 MG/KG X 2 | 1 0.01 77.65 15 ML ORAL | 1 0.01 77.66 15.62 MG, BID; 15.62 MG, QD | 1 0.01 77.67 150 MCG QW SUBCUTANEOUS | 1 0.01 77.68 150 MG (DAILY), ORAL | 1 0.01 77.69 150 MG (THRICE DAILY) | 1 0.01 77.70 150 MG BID PO | 2 0.02 77.72 150 MG DAILY | 1 0.01 77.73 150 MG DAILY ORAL | 1 0.01 77.74 150 MG NIGHTLY | 1 0.01 77.75 150 MG ORAL | 1 0.01 77.76 150 MG, 1 IN 1 DAY, INTRAVENOUS; 200 .. | 1 0.01 77.77 150 MG, DAILY, ORAL | 1 0.01 77.78 150 MG, ORAL | 1 0.01 77.79 150 MG, TID | 1 0.01 77.80 150 MG, UNK | 1 0.01 77.81 150 MG/DAILY/PO | 1 0.01 77.82 150 MG/DAY | 2 0.02 77.84 150 MG/ML IM | 1 0.01 77.85 150 ML, 1 DOSE, INTRA-ARTERIAL | 1 0.01 77.86 150 UG/HR, 1 IN 72 HOUR, TRANSDERMAL | 1 0.01 77.87 150 UNITS/DAY | 1 0.01 77.88 1500 MG 2 TIMES ORAL | 1 0.01 77.89 1500 MG 2/D PC | 1 0.01 77.90 1500 MG 2/D PO | 1 0.01 77.91 1500 MG IV | 1 0.01 77.92 1500 MG ORAL DOSE (500 MG X 3) | 1 0.01 77.93 1500 MG PO | 1 0.01 77.94 1500 MG, QD | 1 0.01 77.95 1500 MG, SEE TEXT, ORAL | 1 0.01 77.96 150MG BID ORAL | 1 0.01 77.97 150MG DAY ORAL | 1 0.01 77.98 150MG PER DAY | 2 0.02 78.00 150MG TWICE PER DAY | 2 0.02 78.02 150MG UNKNOWN | 1 0.01 78.03 150MG, 75MG BID, ORAL | 1 0.01 78.04 1570 MG | 1 0.01 78.05 15G PER DAY | 1 0.01 78.06 15MG ONCE DAILY WHEN REQUIRED | 1 0.01 78.07 15MG PER DAY | 2 0.02 78.09 15U TWICE PER DAY | 1 0.01 78.10 16 MG DAILY PO | 1 0.01 78.11 16 MG IV | 1 0.01 78.12 16.8 MG 1X PER 1 DAY, INTRAVENOUS | 1 0.01 78.13 160 MG ONCE PO | 1 0.01 78.14 160 MG Q2W - INTRAVENOUS NOS | 1 0.01 78.15 160 MG, CYCLIC, IV DRIP | 1 0.01 78.16 160 MG, IV | 1 0.01 78.17 160 MG, ORAL | 3 0.03 78.20 160 MG, QD | 3 0.03 78.23 160 MG/DAY | 1 0.01 78.24 160 MG/M2 EVERY 3 WE IV | 1 0.01 78.25 160.800 MG TWICE DAIL ORAL | 1 0.01 78.26 160/800 MG TWICE DAIL ORAL | 1 0.01 78.27 1600 MG, QD | 1 0.01 78.28 1600 MG/M2/ DAY | 1 0.01 78.29 1600 MG/M2/DAY | 1 0.01 78.30 1600MG PER DAY | 1 0.01 78.31 1600MG, ONCE NIGHTLY, PO | 1 0.01 78.32 160MG PER DAY | 1 0.01 78.33 162 MG Q3WK IVX2 | 1 0.01 78.34 17 GM/ X 1/ IV | 1 0.01 78.35 170 MG DAILY ORAL | 1 0.01 78.36 171 MG, Q3W, INTRAVENOUS | 1 0.01 78.37 175 MG/M2 PER CYCLE | 1 0.01 78.38 18 MCG (18 MCG) | 1 0.01 78.39 18 MCG (18 MCG), IH | 1 0.01 78.40 18 MCG (18 MCG, 1 CAPSULE INHALED DAI.. | 1 0.01 78.41 18 MCG (18 MCG, 1 KAI OAD) IH | 1 0.01 78.42 18 MCG (18 MCG, DAILY), IH | 1 0.01 78.43 18 MCG IH | 1 0.01 78.44 18 MCG, IH | 2 0.02 78.46 18 MG/DAY ORAL | 1 0.01 78.47 180 MG QD ORAL | 1 0.01 78.48 180 MG, UNK, ORAL | 1 0.01 78.49 180 MG/M2 PER_CYCLE | 1 0.01 78.50 1800 MG (TID), ORAL | 1 0.01 78.51 1800 MG, 600 MG Q , IV PIGGY | 1 0.01 78.52 186 MG IV Q 21 DAYS | 1 0.01 78.53 19 TABLETS ORAL | 1 0.01 78.54 19.4 MG, 1 IN 3 MONTHS, INTRAVENOUS | 1 0.01 78.55 1980 MG | 1 0.01 78.56 1CAP PER DAY | 3 0.03 78.59 1DROP TWICE PER DAY | 1 0.01 78.60 1G PER DAY | 2 0.02 78.62 1MG PER DAY | 1 0.01 78.63 1MG TWICE PER DAY | 2 0.02 78.65 1MG/DAY | 1 0.01 78.66 1MGM2 PER DAY | 1 0.01 78.67 1PUFF AT NIGHT | 1 0.01 78.68 1PUFF PER DAY | 5 0.05 78.73 1PUFF TWICE PER DAY | 32 0.32 79.05 1PUFF UNKNOWN | 2 0.02 79.07 1PUFF VARIABLE DOSE | 1 0.01 79.08 1ST DOSE - 21NOV03 | 1 0.01 79.09 1TAB PER DAY | 1 0.01 79.10 1TAB TWICE PER DAY | 4 0.04 79.14 1UNIT PER DAY | 5 0.05 79.19 1X DAY TOPICAL | 1 0.01 79.20 2 APPLICATIONS/DAY | 1 0.01 79.21 2 CC, ONCE, SUBCUTANEOUS | 1 0.01 79.22 2 DF DAILY PO | 1 0.01 79.23 2 DF, BID | 1 0.01 79.24 2 DF, UNK | 2 0.02 79.26 2 DF/DAY | 1 0.01 79.27 2 DOSAGE FORMS (1 DOSAGE FORMS, 2 IN .. | 1 0.01 79.28 2 DROPS EVERY 20MN | 2 0.02 79.30 2 G | 1 0.01 79.31 2 G / DAY | 1 0.01 79.32 2 G DAILY | 1 0.01 79.33 2 G/D | 1 0.01 79.34 2 G/M2 FREQ | 1 0.01 79.35 2 GRAM, INTRAVENOUS | 1 0.01 79.36 2 IN , INTRAVENOUS | 1 0.01 79.37 2 IU, ORAL | 1 0.01 79.38 2 MG | 2 0.02 79.40 2 MG PO | 1 0.01 79.41 2 MG / SIXTEEN TIMES PER DAY / TRA | 1 0.01 79.42 2 MG 1 X PER 1 DAY, ORAL | 1 0.01 79.43 2 MG 1X PER 1 DAY | 1 0.01 79.44 2 MG DAILY ORAL | 1 0.01 79.45 2 MG HS | 1 0.01 79.46 2 MG IV | 1 0.01 79.47 2 MG Q4HR | 1 0.01 79.48 2 MG QIW, 3 MG TIW | 1 0.01 79.49 2 MG, BID, UNK | 1 0.01 79.50 2 MG, IN 1 DAY, ORAL; 3 MG, IN 1 DAY,.. | 1 0.01 79.51 2 MG, ORAL | 1 0.01 79.52 2 MG, QD | 2 0.02 79.54 2 MG, SEE TEXT, UNKNOWN | 2 0.02 79.56 2 MG, } 1 Y AGO | 1 0.01 79.57 2 MG/D | 1 0.01 79.58 2 MG/KG PO 4 WEEKS | 1 0.01 79.59 2 MG/KG PO ONCE | 1 0.01 79.60 2 MG/KG , PO | 1 0.01 79.61 2 MG/KG , PO ONCE | 1 0.01 79.62 2 MG/KG , PO ONCE | 1 0.01 79.63 2 MG/KG PO | 5 0.05 79.68 2 MG/KG PO ONCE | 1 0.01 79.69 2 MG/KG (NR) PO; ONCE | 1 0.01 79.70 2 MG/KG PO | 3 0.03 79.73 2 MG/KG PO, ONCE | 1 0.01 79.74 2 MG/KG PO; ONCE | 2 0.02 79.76 2 MG/KG PO; ONCE | 2 0.02 79.78 2 MG/KG, 1/WEEK, INTRAVENOUS | 1 0.01 79.79 2 MG/KG, IN 1 DAY, ORAL | 1 0.01 79.80 2 MG/KG, PO | 1 0.01 79.81 2 MIU, EVERY 2D, ON TITRATION, SUBCUT.. | 1 0.01 79.82 2 MIU, EVERY 2D, SUBCUTANEOUS | 1 0.01 79.83 2 ML IJ | 4 0.04 79.87 2 PRN | 1 0.01 79.88 2 TAB | 1 0.01 79.89 2 TABLET BID PO | 2 0.02 79.91 2 TABLETS DAILY, ORAL | 1 0.01 79.92 2 TABLETS, BID , ORAL | 1 0.01 79.93 2 TABS EVERY AM AND 1 TAB EVERY EVENING | 1 0.01 79.94 2 U, ORAL | 1 0.01 79.95 2 U, WEEKLY, SUBCUTANEOUS | 1 0.01 79.96 2 UKN, TID | 1 0.01 79.97 2 UNIT 1X PER 1 DAY; ORAL | 1 0.01 79.98 2-500 MG 4-6 HRS/PR ORAL | 1 0.01 79.99 2.00 MG TID | 1 0.01 80.00 2.2 MG, 4 IN 1 DAY, | 1 0.01 80.01 2.5 BOTTLE ONCE PO | 1 0.01 80.02 2.5 MG | 2 0.02 80.04 2.5 MG (DAILY), ORAL | 1 0.01 80.05 2.5 MG 1X PER 1 DAY | 1 0.01 80.06 2.5 MG 2 DAYS A W ORAL | 1 0.01 80.07 2.5 MG 2X PER 1 DAY, ORAL | 1 0.01 80.08 2.5 MG IT | 1 0.01 80.09 2.5 MG OD, ORAL | 1 0.01 80.10 2.5 MG OD, SUBCUTANEOUS | 1 0.01 80.11 2.5 MG PO | 1 0.01 80.12 2.5 MG PRN PO | 1 0.01 80.13 2.5 MG, 2 IN 1 DAY, ORAL | 1 0.01 80.14 2.5 MG, QD | 2 0.02 80.16 2.5 MG, UNK | 2 0.02 80.18 2.5 MG/D | 2 0.02 80.20 2.5 MG/DAY | 2 0.02 80.22 2.5 NG/KG/MIN DAILY SC | 1 0.01 80.23 2.5 VIALS | 1 0.01 80.24 2.5MG UNKNOWN | 1 0.01 80.25 2.6 MG BIW : INTRAVENOUS BOLUS | 1 0.01 80.26 2.6 MG BIW, INTRAVENOUS BOLUS | 1 0.01 80.27 2/100 | 1 0.01 80.28 2/D | 1 0.01 80.29 2/D PO | 1 0.01 80.30 20 UG/DAY, CONT, INTRA-UTERINE | 1 0.01 80.31 20 G, QD | 1 0.01 80.32 20 GM X 1 IV | 3 0.03 80.35 20 MG | 2 0.02 80.37 20 MG (15 TABLETS ON 24-NOV) NOT CLE.. | 1 0.01 80.38 20 MG (DAILY) | 1 0.01 80.39 20 MG (DAILY), ORAL | 2 0.02 80.41 20 MG (DAILY), RECTAL | 1 0.01 80.42 20 MG 2 X PER 1 DAY, ORAL | 1 0.01 80.43 20 MG AS NEEDED ORAL | 1 0.01 80.44 20 MG DAILY ORAL | 1 0.01 80.45 20 MG DAILY PO | 5 0.05 80.50 20 MG IN | 1 0.01 80.51 20 MG ONCE AURICULAR | 1 0.01 80.52 20 MG ONCE PO | 1 0.01 80.53 20 MG PO | 1 0.01 80.54 20 MG PO BID | 1 0.01 80.55 20 MG PRN PO | 1 0.01 80.56 20 MG Q DAY PO | 1 0.01 80.57 20 MG QD IV | 1 0.01 80.58 20 MG QD ORAL | 2 0.02 80.60 20 MG QD PO | 14 0.14 80.74 20 MG QDAY PO | 1 0.01 80.75 20 MG WEEKLY | 1 0.01 80.76 20 MG, 2 IN 1 DAY | 1 0.01 80.77 20 MG, BID | 1 0.01 80.78 20 MG, BID, INTRAVENOUS | 1 0.01 80.79 20 MG, BID, ORAL | 1 0.01 80.80 20 MG, DAILY, ORAL | 1 0.01 80.81 20 MG, IN 1 DAY, ORAL | 1 0.01 80.82 20 MG, QD | 5 0.05 80.87 20 MG, QD/MANE | 1 0.01 80.88 20 MG, QHS | 1 0.01 80.89 20 MG, SEE TEXT, ORAL | 1 0.01 80.90 20 MG, TID, ORAL | 2 0.02 80.92 20 MG, UNK | 3 0.03 80.95 20 MG, WEEKLY, INTRAMUSCUALR | 1 0.01 80.96 20 MG/D | 4 0.04 81.00 20 MG/DAY | 3 0.03 81.03 20 MG/KG /HR | 1 0.01 81.04 20 MG/M2 AS 2 HOURS INFUSION ON D1-D2.. | 1 0.01 81.05 20 MILLIGRAM, SUBCUTANEOUS | 2 0.02 81.07 20 ML | 1 0.01 81.08 20 ML, 2 IN 1 DAY, | 1 0.01 81.09 20 UG/DAY, CONT, INTRA-UTERINE | 2 0.02 81.11 20 UG/ML | 1 0.01 81.12 20.00 MG, BID, ORAL | 1 0.01 81.13 200 + 300 MG, INTRAVENOUS | 1 0.01 81.14 200 DOSE(S), ORAL | 1 0.01 81.15 200 MG | 4 0.04 81.19 200 MG (DAILY) | 1 0.01 81.20 200 MG (QID), ORAL | 1 0.01 81.21 200 MG (UNSPECIFIED DOSAGE AND FEQUEN.. | 1 0.01 81.22 200 MG (UNSPECIFIED); ORAL | 1 0.01 81.23 200 MG 1X PER 1 DAY | 3 0.03 81.26 200 MG 1X PER 1 DAY ORAL | 1 0.01 81.27 200 MG 2/D PO | 2 0.02 81.29 200 MG 3X PER 1 WK; ORAL | 1 0.01 81.30 200 MG BID PO | 1 0.01 81.31 200 MG DAILY ORAL | 3 0.03 81.34 200 MG DAILY PO | 1 0.01 81.35 200 MG DAILY, ORAL | 1 0.01 81.36 200 MG FREQ | 1 0.01 81.37 200 MG FREQ UNK | 1 0.01 81.38 200 MG IV OUT SECONDARY | 1 0.01 81.39 200 MG ONCE - INTRAVENOUS NOS | 1 0.01 81.40 200 MG ONCE IV | 1 0.01 81.41 200 MG ONCE PO | 1 0.01 81.42 200 MG ORAL | 1 0.01 81.43 200 MG PO | 1 0.01 81.44 200 MG PO BID X 28 DOSES | 1 0.01 81.45 200 MG PO DAILY | 1 0.01 81.46 200 MG PO QHS | 1 0.01 81.47 200 MG Q 21 DAYS IV | 1 0.01 81.48 200 MG QD | 1 0.01 81.49 200 MG QD PO | 1 0.01 81.50 200 MG TID-QID | 1 0.01 81.51 200 MG, 1 IN 6 WEEK, INTRAVENOUS | 2 0.02 81.53 200 MG, 2 IN 1 D, PER ORAL | 1 0.01 81.54 200 MG, 2 IN 1 DAY, ORAL | 1 0.01 81.55 200 MG, BID | 2 0.02 81.57 200 MG, DAILY, ORAL | 6 0.06 81.63 200 MG, INTRAVENOUS | 1 0.01 81.64 200 MG, ORAL | 2 0.02 81.66 200 MG, PRN, ORAL | 1 0.01 81.67 200 MG, QD | 2 0.02 81.69 200 MG, QD, ORAL | 2 0.02 81.71 200 MG, SEE TEXT, UNKNOWN | 1 0.01 81.72 200 MG, SINGLE, INTRAVENOUS | 2 0.02 81.74 200 MG/ ORAL | 1 0.01 81.75 200 MG/D | 1 0.01 81.76 200 MG/DAY | 1 0.01 81.77 200 MG/M2 AS 2 HOURS INFUSION ON D1-D.. | 1 0.01 81.78 200 MG5X PER 1 WK; ORAL | 1 0.01 81.79 200 ML ONCE OTHER | 1 0.01 81.80 200 UG/DAY | 1 0.01 81.81 200 UG; TIW; SUBCUTANEOUS | 1 0.01 81.82 200-100 MG/D | 1 0.01 81.83 200-300 NG | 1 0.01 81.84 200-500MG QD ORAL | 1 0.01 81.85 2000 MG, 1 IN 1 D, PER ORAL | 1 0.01 81.86 2000.0 MG; QD; PO | 1 0.01 81.87 200MCG TWICE PER DAY | 1 0.01 81.88 200MG IN THE MORNING, AND 400MG AT NI.. | 1 0.01 81.89 200MG PER DAY | 3 0.03 81.92 200MG PO Q AM 400 MG PO QHS | 1 0.01 81.93 200MG TWICE PER DAY | 5 0.05 81.98 20MG AT NIGHT | 1 0.01 81.99 20MG DAILY ORAL | 1 0.01 82.00 20MG PER DAY | 3 0.03 82.03 20MG QD ORAL | 2 0.02 82.05 20MG TWICE PER DAY | 2 0.02 82.07 20MG/D DAYS -8 TO -4 | 1 0.01 82.08 20MG/D, DAYS -8 TO-4 | 1 0.01 82.09 20MG/DAY (DAYS -8 TO -4) | 1 0.01 82.10 20MG/DAY DAYS -8 TO -4 | 1 0.01 82.11 20TAB SINGLE DOSE | 1 0.01 82.12 21 MG / PER DAY / TRANSDERMAL | 1 0.01 82.13 21 MG / SINGLE DOSE / TRANSDERMAL | 1 0.01 82.14 21 MG/DAY | 1 0.01 82.15 210 MG/M2, WEEKLY FOR FOUR WEEKS, INT.. | 2 0.02 82.17 210 MG/M2, WEEKLY FOR FOUR WEEKS,INTR.. | 1 0.01 82.18 2100 MG PE 1 X ONLY INTRAVENOUS | 1 0.01 82.19 211 MG, 1X/WEEK X 4WKS, INTRAVENOUS | 1 0.01 82.20 21MCG TWICE PER DAY | 1 0.01 82.21 21MCG UNKNOWN | 2 0.02 82.23 22 MG 1 X PER 1 DAY, INTRAVENOUS | 1 0.01 82.24 22-MAR-2003 TO 11-APR-2003; 15-APR-2.. | 1 0.01 82.25 220 MG, ONCE, ORAL | 1 0.01 82.26 220 MG, PRN, ORAL | 1 0.01 82.27 220MCG FOUR TIMES PER DAY | 1 0.01 82.28 220MCG PER DAY | 3 0.03 82.31 220MCG THREE TIMES PER DAY | 2 0.02 82.33 220MCG TWICE PER DAY | 23 0.23 82.56 220MCG UNKNOWN | 5 0.05 82.61 222 MG Q DAY IV | 1 0.01 82.62 23 MG, 1 IN 30 D, INTRAMUSCULAR | 1 0.01 82.63 23.5 GM X 1 IV | 1 0.01 82.64 233 MG, CYCLIC, IV | 1 0.01 82.65 24 MG, 1 IN 30 D, INTRAMUSCLAR | 1 0.01 82.66 240 MG QD | 1 0.01 82.67 2400 MG (QID) | 1 0.01 82.68 2400 MG /D PC | 1 0.01 82.69 240MG PER DAY | 1 0.01 82.70 24MG TWICE PER DAY | 1 0.01 82.71 25 MCG/HR (SEE TEXT), TO | 1 0.01 82.72 25 MG | 1 0.01 82.73 25 MG (DAILY), ORAL | 2 0.02 82.75 25 MG (DAILY), ORAL/ABOUT 9 YEARS AGO | 1 0.01 82.76 25 MG 1 X PER 1 DAY, ORAL | 1 0.01 82.77 25 MG 1X PER 1 DAY ORAL | 1 0.01 82.78 25 MG 2/WK | 1 0.01 82.79 25 MG 2X PER 1 WK, SC | 1 0.01 82.80 25 MG 2X PR 1 WK , SC | 1 0.01 82.81 25 MG BID | 1 0.01 82.82 25 MG BID PO | 1 0.01 82.83 25 MG DAILY ORAL | 1 0.01 82.84 25 MG DAILY PO | 1 0.01 82.85 25 MG IV-PUSH | 1 0.01 82.86 25 MG PO | 1 0.01 82.87 25 MG Q DAY | 1 0.01 82.88 25 MG QD ORAL | 1 0.01 82.89 25 MG WEEKLY SC | 2 0.02 82.91 25 MG, 1 IN WEEK, INTRA-MUSCULAR | 1 0.01 82.92 25 MG, 1 IN 2 WEEK, INTRA-MUSCULAR | 1 0.01 82.93 25 MG, 1 IN 2 WEEK, INTRAMUSCULAR | 1 0.01 82.94 25 MG, 1 IN 30 D, INTRAMUSCULAR | 1 0.01 82.95 25 MG, 2 IN 1 WEEKS, SC | 1 0.01 82.96 25 MG, DAILY, ORAL | 2 0.02 82.98 25 MG, ORAL | 1 0.01 82.99 25 MG, QD | 1 0.01 83.00 25 MG, QD, PRN | 1 0.01 83.01 25 MG/D | 1 0.01 83.02 25 MG/DAY | 1 0.01 83.03 25 MG/M2 DAY 1, 8 Q 21 DAYS IV | 1 0.01 83.04 25 MG/M2 IV | 1 0.01 83.05 25 MICROGRAM Q1 HR | 1 0.01 83.06 25 UG/HR, 1 IN 72 HOUR, TRANSDERMAL | 2 0.02 83.08 25 UG/HR, TRANSDERMAL | 1 0.01 83.09 25-50-75 UG/D | 1 0.01 83.10 250 GM DAILY PO | 1 0.01 83.11 250 MG (Q48H), INTRAVENOUS | 1 0.01 83.12 250 MG / DAY | 1 0.01 83.13 250 MG 1X PER 1 DAY; 225 MG 1X PER 1 .. | 1 0.01 83.14 250 MG 2/D | 1 0.01 83.15 250 MG DAILY PO | 9 0.09 83.24 250 MG ORAL | 1 0.01 83.25 250 MG PO | 2 0.02 83.27 250 MG PO QD | 1 0.01 83.28 250 MG QD ORAL | 1 0.01 83.29 250 MG QD PO | 3 0.03 83.32 250 MG TID ORAL | 1 0.01 83.33 250 MG X 1 IV OVER 90 MIN | 1 0.01 83.34 250 MG, 2 IN 1 D, PER ORAL | 1 0.01 83.35 250 MG, BID | 1 0.01 83.36 250 MG, INTRAVENOUS | 2 0.02 83.38 250 MG, QD | 2 0.02 83.40 250 MG, TID | 1 0.01 83.41 250 MG, TOTAL DAILY, ORAL | 1 0.01 83.42 250 MG, UNK | 2 0.02 83.44 250 MG/DAY | 2 0.02 83.46 250 MG/ML IM | 1 0.01 83.47 250 UG, SINGLE, INT CORP CARRN | 1 0.01 83.48 250-500 MG TWICE DAILY | 1 0.01 83.49 250.00 MG, UID/QD, INTRAVENOUS | 1 0.01 83.50 2500 IU, QD, UNK | 1 0.01 83.51 2500 MG PO X 10 DAYS | 1 0.01 83.52 2500 MG/D FOR 5 D/WK | 1 0.01 83.53 2500 MG/D FOR 6 D/WK | 1 0.01 83.54 2500 MG/DAILY, PO | 1 0.01 83.55 2500MG PER DAY | 1 0.01 83.56 250MCG INHALATION | 1 0.01 83.57 250MG PER DAY | 1 0.01 83.58 250MG TID OTHER | 1 0.01 83.59 252 MG; Q3W; INTRAVENOUS | 1 0.01 83.60 258 MG 7 DAYS INTRAVENOUS | 1 0.01 83.61 258MG/232 3 DAYS /3D INTRAVENOUS | 1 0.01 83.62 25MCG TWICE PER DAY | 1 0.01 83.63 25MG MANE + 50MG NOCTE | 1 0.01 83.64 25MG PER DAY | 4 0.04 83.68 25MG TWICE PER DAY | 1 0.01 83.69 25MG X2 SUBCUTANEOUS | 1 0.01 83.70 25MG/DAY | 4 0.04 83.74 25MGM2 IV Q EVERY 28 DAYS NEXT DOSE S.. | 1 0.01 83.75 26-MAR-2003 TO 06-APR-2003; 29-APR-20.. | 1 0.01 83.76 260 MG IV | 1 0.01 83.77 27 MG DAILY + | 1 0.01 83.78 27 MG, 1 IN 30 D, INTRAMUSCULAR | 1 0.01 83.79 2700 MG (BID), ORAL | 1 0.01 83.80 271.6 MG, SINGLE , INTRAVENOUS | 1 0.01 83.81 275MG MANE + 300MG NOCTE | 1 0.01 83.82 28 TABLET AS DIRECTE ORAL | 1 0.01 83.83 280 MG PO TID X 14 D Q21 D | 1 0.01 83.84 2G PER DAY | 2 0.02 83.86 2MG PER DAY | 1 0.01 83.87 2MG SINGLE DOSE | 1 0.01 83.88 2MG TWICE PER DAY | 1 0.01 83.89 2PUFF AS REQUIRED | 3 0.03 83.92 2PUFF IN THE MORNING | 2 0.02 83.94 2PUFF PER DAY | 3 0.03 83.97 2PUFF THREE TIMES PER DAY | 1 0.01 83.98 2PUFF TWICE PER DAY | 93 0.93 84.91 2PUFF UNKNOWN | 2 0.02 84.93 2PUFF VARIABLE DOSE | 2 0.02 84.95 2PUFFS/BID | 1 0.01 84.96 2SPR IN THE MORNING | 1 0.01 84.97 2SPR TWICE PER DAY | 2 0.02 84.99 2TABS WHEN NEEDE ORAL | 1 0.01 85.00 2U, ORAL | 1 0.01 85.01 3 CAPS/DAY | 1 0.01 85.02 3 DF, UNK | 2 0.02 85.04 3 DF/D | 1 0.01 85.05 3 DF/DAY | 1 0.01 85.06 3 DOSAGE FORMS (1 DOSAGE FORMS, 3 IN .. | 1 0.01 85.07 3 DOSAGE FORMS ORAL | 1 0.01 85.08 3 FEB 2004 - 13 FEB 2004, 4MG PER DAY.. | 1 0.01 85.09 3 G DAILY PO | 1 0.01 85.10 3 G, IV | 1 0.01 85.11 3 G/D | 1 0.01 85.12 3 IN 1 WEEK (S), TOPICAL APPROXIMATE.. | 1 0.01 85.13 3 MG 1X PER 1 DAY, ORAL | 1 0.01 85.14 3 MG 5 DAYS A W ORAL | 1 0.01 85.15 3 MG DAILY ORAL | 1 0.01 85.16 3 MG, 6QD | 1 0.01 85.17 3 MG, QD | 1 0.01 85.18 3 MG/KG, 1 IN 1 AS NECESSARY, INTRAVE.. | 3 0.03 85.21 3 MG/KG, INTRAVENOUS | 1 0.01 85.22 3 MG/KG/DAY, INTRAVENOUS | 3 0.03 85.25 3 MIU INTRAMUSCULAR | 1 0.01 85.26 3 TABLETS DAILY, ORAL | 1 0.01 85.27 3 WEEKS ADMINISTRATION 1 WEEK REST. | 1 0.01 85.28 3 WEEKS ADMINISTRATION 2 WEEKS REST. | 1 0.01 85.29 3.0 MG (1.3 MG/M2): INTRAVENOUS BOLUS | 1 0.01 85.30 3.00 MG, BID, ORAL | 1 0.01 85.31 3.00 MG, ORAL; SEE IMAGE | 1 0.01 85.32 3.375 G Q6H IV | 1 0.01 85.33 3.50 MG, TID, ORAL | 1 0.01 85.34 3.6 MG Q4WK SQ | 1 0.01 85.35 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTAN.. | 1 0.01 85.36 3.75 MG, QD | 1 0.01 85.37 30 + 60 MG, ORAL | 1 0.01 85.38 30 , MCG, SC | 1 0.01 85.39 30 GM Q 24 H X 3 IV | 1 0.01 85.40 30 GM QD X 5 DAYS | 1 0.01 85.41 30 JUL 2003 - 13 FEB 2004, 10MG PER D.. | 1 0.01 85.42 30 JUN 2003 TO 27 JUL 2003, PATIENT R.. | 1 0.01 85.43 30 MCG IM | 1 0.01 85.44 30 MCG QW I M | 1 0.01 85.45 30 MCG QW IM | 78 0.78 86.23 30 MG | 1 0.01 86.24 30 MG (30 MG, 1 IN 1 D) | 1 0.01 86.25 30 MG (30 MG, 1 IN 1 D) PER ORAL | 1 0.01 86.26 30 MG (30 MG, DAILY X5), IVI | 1 0.01 86.27 30 MG (THRICE DAILY) | 1 0.01 86.28 30 MG /M2 IV Q W | 1 0.01 86.29 30 MG DAILY (047) ORALLY | 1 0.01 86.30 30 MG DAILY ORAL | 2 0.02 86.32 30 MG Q4H AND 60 MG AT NIGHT | 1 0.01 86.33 30 MG QD | 1 0.01 86.34 30 MG QD PO | 3 0.03 86.37 30 MG, 1 IN 1 D, PER ORAL; 45 MG, 1 I.. | 1 0.01 86.38 30 MG, 1 IN 1 DAY,ORAL | 1 0.01 86.39 30 MG, 1 IN 30 D, INTRAMUSCULAR | 1 0.01 86.40 30 MG, 1X/DAY:QD | 1 0.01 86.41 30 MG, QD | 1 0.01 86.42 30 MG, SINGLE, IV; | 1 0.01 86.43 30 MG/D | 1 0.01 86.44 30 MG/DAY | 1 0.01 86.45 30 MIL TWICE A DA ORAL | 1 0.01 86.46 30 U, QD, SUBCUTANEOUS | 1 0.01 86.47 30-10 MG/D | 1 0.01 86.48 300 MCG, 1 IN 3 WEEKS, SC | 1 0.01 86.49 300 MG | 2 0.02 86.51 300 MG (100 MG) PO | 1 0.01 86.52 300 MG (DAILY), ORAL | 2 0.02 86.54 300 MG , 1 IN 1 D, PER ORAL | 1 0.01 86.55 300 MG / DAY | 1 0.01 86.56 300 MG 2/D PC | 1 0.01 86.57 300 MG 2/D PO | 1 0.01 86.58 300 MG AES#DOSE_FREQUENCY: DLY | 1 0.01 86.59 300 MG BID ORAL | 1 0.01 86.60 300 MG DAILY | 1 0.01 86.61 300 MG DAILY AT BEDTIME | 1 0.01 86.62 300 MG DAILY PO | 1 0.01 86.63 300 MG DAILY; ORAL | 1 0.01 86.64 300 MG IV Q 8 WKS | 1 0.01 86.65 300 MG IV Q DAY | 1 0.01 86.66 300 MG ONCE PO | 1 0.01 86.67 300 MG OTH IV | 1 0.01 86.68 300 MG PO QD | 1 0.01 86.69 300 MG QD PO | 3 0.03 86.72 300 MG TID BY MOUTH | 1 0.01 86.73 300 MG, 1 IN 1 D, PER ORAL | 1 0.01 86.74 300 MG, 1 IN 8 WEEK, INTRAVENOUS | 1 0.01 86.75 300 MG, BID | 1 0.01 86.76 300 MG, DAILY, ORAL | 1 0.01 86.77 300 MG, ONCE A DAY, ORAL | 4 0.04 86.81 300 MG, QD | 1 0.01 86.82 300 MG/30 MG - - ONE TABLET, AS NEEDED | 1 0.01 86.83 300 MG/D | 3 0.03 86.86 300 UG/DAY | 1 0.01 86.87 3000 MG (DAILY) | 1 0.01 86.88 300MG PER DAY | 10 0.10 86.98 300MG UNKNOWN | 1 0.01 86.99 300MG/DAY | 1 0.01 87.00 30MG AT NIGHT | 1 0.01 87.01 30MG PER DAY | 2 0.02 87.03 30MG/DAY | 1 0.01 87.04 30MG/M2 (DAYS -7 TO -3) | 1 0.01 87.05 30MG/M2 DAYS -7 TO -3 | 3 0.03 87.08 31,000 IN SQ QW | 1 0.01 87.09 31.5-500MG QD ORAL | 1 0.01 87.10 315 MG IV | 1 0.01 87.11 318 MG FREQ | 1 0.01 87.12 32 IU, QD, INTRAUTERINE | 1 0.01 87.13 32 NG/KG/MIN CONTINUOUS IV | 1 0.01 87.14 320 MG AT EVENT ONSET; 280 MG DAILY | 1 0.01 87.15 320 MG, QD | 2 0.02 87.17 3200 UNITS Q2WKS IV | 1 0.01 87.18 320MG PER DAY | 1 0.01 87.19 332 MG; Q3W; INTRAVENOUS | 1 0.01 87.20 34 MG ONCE WEEKLY X 4 WEEKS, INTRAVEN.. | 1 0.01 87.21 3400 UNITS Q2WKS IV | 1 0.01 87.22 350 MG Q2W; INTRAVENOUS NOS | 1 0.01 87.23 350 MG X5D/MO ORAL | 1 0.01 87.24 350 MG/CYCLE ORAL | 1 0.01 87.25 350MG QD, ORAL | 1 0.01 87.26 36 MG, IN 1 DAY, ORAL | 1 0.01 87.27 3600 MG (DAILY), ORAL | 2 0.02 87.29 366MG IV - Q 3 WKS | 1 0.01 87.30 37.5 MG 1 X PER 1 DAY, ORAL | 1 0.01 87.31 37.5 MG, TID | 1 0.01 87.32 375 MG/M2, INTRAVENOUS | 1 0.01 87.33 375 MG/M2, SINGLE , INTRAVENOUS | 1 0.01 87.34 392 MG PER DAY IV | 1 0.01 87.35 398 MG, 1593 MG | 1 0.01 87.36 3G PER DAY | 1 0.01 87.37 3MG PER DAY | 1 0.01 87.38 3PUFF PER DAY | 1 0.01 87.39 3PUFF TWICE PER DAY | 1 0.01 87.40 3UNIT PER DAY | 2 0.02 87.42 4 CAPSUL TWICE DAIL ORAL | 1 0.01 87.43 4 MG | 1 0.01 87.44 4 MG SL | 1 0.01 87.45 4 MG (DAILY), ORAL | 3 0.03 87.48 4 MG , 4 MG Q PM, ORAL | 1 0.01 87.49 4 MG / FOURTEEN TIMES PER DAY / TR | 1 0.01 87.50 4 MG / SIXTEEN TIMES PER DAY / TRA | 1 0.01 87.51 4 MG 1 X PER 1 DAY, ORAL | 2 0.02 87.53 4 MG 1X PER 1 DAY | 1 0.01 87.54 4 MG 1X PER 1 WK, ORAL | 1 0.01 87.55 4 MG EVERY 28 DAYS | 1 0.01 87.56 4 MG EVERY 3-6 WEEKS | 1 0.01 87.57 4 MG EVERY 4 WEEKS | 2 0.02 87.59 4 MG EVERY MONTH | 1 0.01 87.60 4 MG MONTHLY | 1 0.01 87.61 4 MG ORAL | 1 0.01 87.62 4 MG PER MONTH | 1 0.01 87.63 4 MG PO DAILY | 1 0.01 87.64 4 MG PO TID | 1 0.01 87.65 4 MG Q8 HOURS IV | 1 0.01 87.66 4 MG QD PO | 1 0.01 87.67 4 MG, | 1 0.01 87.68 4 MG, 2 IN 1 DAY, ORAL | 1 0.01 87.69 4 MG, IN 1 DAY, ORAL | 1 0.01 87.70 4 MG, QD | 1 0.01 87.71 4 MG, QMO | 3 0.03 87.74 4 MG, UNK | 2 0.02 87.76 4 MG/AS REQUIRED/ TRANSBUCCAL | 1 0.01 87.77 4 MG/D | 1 0.01 87.78 4 MG/KG, SINGLE, INTRAVENOUS | 1 0.01 87.79 4 MG/M2 (6.5MG) | 1 0.01 87.80 4 MGS 5 PER DAY ORAL | 1 0.01 87.81 4 MU IV Q 8 H | 1 0.01 87.82 4 TABLET QD PO | 1 0.01 87.83 4. 5 G 3X PER 1 DAY | 1 0.01 87.84 4.2 MG/KG /HR | 1 0.01 87.85 4.35 MG, IN 1 DAY, INTRAVENOUS DRIP | 1 0.01 87.86 40 DF, BID | 1 0.01 87.87 40 MG | 3 0.03 87.90 40 MG (DAILY), ORAL | 1 0.01 87.91 40 MG /M2 IV QWK X6 | 1 0.01 87.92 40 MG BID | 1 0.01 87.93 40 MG BID ORAL | 4 0.04 87.97 40 MG DAILY ORAL | 4 0.04 88.01 40 MG DAILY PO | 4 0.04 88.05 40 MG ORAL | 1 0.01 88.06 40 MG PO | 1 0.01 88.07 40 MG QD IV | 1 0.01 88.08 40 MG QD PO | 3 0.03 88.11 40 MG X 4 DAYS EVERY 2 WEEKS | 1 0.01 88.12 40 MG, 1 IN 2 WK, SUBCUTANEOUS | 2 0.02 88.14 40 MG, 1 IN 2 WK, SUBCUTANOUES | 1 0.01 88.15 40 MG, 2/WEEK, INTRAVENOUS | 1 0.01 88.16 40 MG, Q12H | 1 0.01 88.17 40 MG, QD | 2 0.02 88.19 40 MG, SEE TEXT, UNKNOWN | 1 0.01 88.20 40 MG, SUBCUTANEOUS | 1 0.01 88.21 40 MG-TWICE A DAY | 1 0.01 88.22 40 MG/D | 1 0.01 88.23 40 MG/DAILY PO | 1 0.01 88.24 40 MG/DAY | 2 0.02 88.26 40 MG/KG/D FOR 5D EVERY 2-3 MO | 1 0.01 88.27 40 MGS A DAY | 1 0.01 88.28 40 UG, UNK, INT CORP CAVERN | 1 0.01 88.29 400 M/DAILY, PO | 1 0.01 88.30 400 MCG, TRANSDERMAL | 1 0.01 88.31 400 MG (BID), ORAL | 1 0.01 88.32 400 MG (UNKNOWN); ORAL | 1 0.01 88.33 400 MG 1X PER 1 DAY; ORAL | 1 0.01 88.34 400 MG 2/D PO | 1 0.01 88.35 400 MG BID ORAL | 3 0.03 88.38 400 MG DAILY | 2 0.02 88.40 400 MG DAILY P.O. | 1 0.01 88.41 400 MG ONE Q DAY X 10 DAYS | 1 0.01 88.42 400 MG ONE QD X 10 DAYS | 1 0.01 88.43 400 MG ORAL | 1 0.01 88.44 400 MG OTH PO | 1 0.01 88.45 400 MG QD ORAL | 3 0.03 88.48 400 MG QD PO | 1 0.01 88.49 400 MG, IN 1 DAY | 1 0.01 88.50 400 MG, 1 IN 1 DAY, ORAL | 1 0.01 88.51 400 MG, BID | 1 0.01 88.52 400 MG, DAILY , ORAL | 1 0.01 88.53 400 MG, DAILY, ORAL | 1 0.01 88.54 400 MG, INTRAVENOUS | 1 0.01 88.55 400 MG, ONCE, ORAL | 1 0.01 88.56 400 MG, ORAL | 3 0.03 88.59 400 MG, QD | 2 0.02 88.61 400 MG, TOTAL DAILY, ORAL | 2 0.02 88.63 400 MG, UNK | 2 0.02 88.65 400 MG/D | 8 0.08 88.73 400 MG/DAY | 3 0.03 88.76 400 MG/M2 AS IV BOLUS THAN 600 MG/M2 .. | 1 0.01 88.77 400 MG/M2 AS IV BOLUS THEN 600 MG/M2 .. | 1 0.01 88.78 400 MG/M2 BOLUS THEN 2400 MG.M2 AS 46.. | 1 0.01 88.79 400/50MG (SEE TEXT, 200MG/25MG 1 CAP .. | 1 0.01 88.80 400MG PER DAY | 9 0.09 88.89 400MG, 400MG QH, ORAL | 1 0.01 88.90 400MG/DAY | 1 0.01 88.91 40DROP THREE TIMES PER DAY | 1 0.01 88.92 40MG PER DAY | 5 0.05 88.97 40MG TWICE PER DAY | 2 0.02 88.99 40MG, 40MG QD,ORAL | 1 0.01 89.00 42 MG IV | 1 0.01 89.01 423 MCG/DAY X5 DAYS/WEEK, SUBCUTANEOUS | 1 0.01 89.02 42MCG UNKNOWN | 1 0.01 89.03 44 MCG, 3 IN 1 WEEKS, | 1 0.01 89.04 440 MG, ONCE, ORAL | 1 0.01 89.05 440MCG TWICE PER DAY | 4 0.04 89.09 440MCG UNKNOWN | 1 0.01 89.10 44MCG PER DAY | 2 0.02 89.12 44MCG TWICE PER DAY | 4 0.04 89.16 44MCG UNKNOWN | 4 0.04 89.20 44TAB SINGLE DOSE | 1 0.01 89.21 45 MG | 1 0.01 89.22 45 MG ORAL | 1 0.01 89.23 45 MG, HS | 1 0.01 89.24 45 MG, QD,; SEE IMAGE | 1 0.01 89.25 45 MG, UNK | 1 0.01 89.26 45 MG/DAY ORAL | 1 0.01 89.27 45 MG/M2 IV | 1 0.01 89.28 45 UNITS PRN IM | 1 0.01 89.29 450 MG DAILY | 1 0.01 89.30 450 MG, INTRAVENOUS | 1 0.01 89.31 450MG CUMULATIVE DOSE | 1 0.01 89.32 450MG/DAY | 1 0.01 89.33 4600 UNITS Q2WKS IV | 1 0.01 89.34 480 MG, Q12H, ORAL | 1 0.01 89.35 490 MG, INTRAVENOUS | 1 0.01 89.36 493 MG IV Q 3 WKS | 1 0.01 89.37 495 MG, CYCLIC, IV BOLUS; 1485 MG,CYC.. | 1 0.01 89.38 4MG PER DAY | 6 0.06 89.44 4MG SINGLE DOSE | 1 0.01 89.45 4MG SIX TIMES PER DAY | 1 0.01 89.46 4PUFF PER DAY | 3 0.03 89.49 4PUFF TWICE PER DAY | 2 0.02 89.51 4SPR PER DAY | 2 0.02 89.53 5 CAPSULES PER DAY (NR), PO; 4 CAPSUL.. | 1 0.01 89.54 5 CAPSULES PER DAY , PO | 1 0.01 89.55 5 GMQ AM | 1 0.01 89.56 5 MG | 2 0.02 89.58 5 MG (DAILY), ORAL | 4 0.04 89.62 5 MG (DAILY), ORAL/ABOUT 9 YEARS AGO | 1 0.01 89.63 5 MG AMLOD/20 MG BENAZ | 1 0.01 89.64 5 MG BID PO | 2 0.02 89.66 5 MG DAILY | 1 0.01 89.67 5 MG DAILY AS NEEDED,STOPPED (DATE UN.. | 1 0.01 89.68 5 MG DAILY ORAL | 1 0.01 89.69 5 MG DAILY PO | 1 0.01 89.70 5 MG DAILY, ORAL | 1 0.01 89.71 5 MG PO | 1 0.01 89.72 5 MG PO QD | 1 0.01 89.73 5 MG QD ORAL | 1 0.01 89.74 5 MG QD PO | 13 0.13 89.87 5 MG QHS PO | 2 0.02 89.89 5 MG X 1 DAILY ORAL IN AM | 1 0.01 89.90 5 MG, BID | 1 0.01 89.91 5 MG, BID, ORAL | 1 0.01 89.92 5 MG, DAILY, ORAL | 1 0.01 89.93 5 MG, ORAL | 2 0.02 89.95 5 MG, PRN | 1 0.01 89.96 5 MG, QD | 7 0.07 90.03 5 MG, QD, | 1 0.01 90.04 5 MG, QD, ORAL | 1 0.01 90.05 5 MG, UNK | 1 0.01 90.06 5 MG/D | 1 0.01 90.07 5 MG/DAY | 2 0.02 90.09 5 MG/KG ONCE | 1 0.01 90.10 5 MG/KG, 1 IN 1 DAY, INTRAVENOUS | 1 0.01 90.11 5 MG/KG, INTRAVENOUS | 7 0.07 90.18 5 MG/KG, UID/QD, INTRAVENOUS | 1 0.01 90.19 5 MG/KG,INTRAVENOUS | 1 0.01 90.20 5 MG; IN PM; PO | 1 0.01 90.21 5 ML, ONCE, ORAL | 1 0.01 90.22 5 ML, SUBCUTANEOUS | 1 0.01 90.23 5 TABS AT BEDTIME | 1 0.01 90.24 5 UNITS/KG/HOUR | 3 0.03 90.27 5 VIALS | 1 0.01 90.28 5.00 MG, UID/QD, ORAL | 1 0.01 90.29 50 MCG, QHS, ORAL | 1 0.01 90.30 50 MG | 1 0.01 90.31 50 MG (AT BEDTIME) | 1 0.01 90.32 50 MG (DAILY), ORAL | 2 0.02 90.34 50 MG / DAY | 2 0.02 90.36 50 MG BID | 2 0.02 90.38 50 MG BID PO | 1 0.01 90.39 50 MG DAILY | 2 0.02 90.41 50 MG DAILY PO | 3 0.03 90.44 50 MG DAILY, ORAL | 1 0.01 90.45 50 MG IV PRN | 1 0.01 90.46 50 MG IV X 1 | 1 0.01 90.47 50 MG PO DAILY | 1 0.01 90.48 50 MG PRN PO | 1 0.01 90.49 50 MG Q 12 H SQ | 1 0.01 90.50 50 MG Q12H (NR, 1 IN 12 HR) | 1 0.01 90.51 50 MG TID | 1 0.01 90.52 50 MG X2 | 1 0.01 90.53 50 MG, 3 IN 1 DAY | 1 0.01 90.54 50 MG, 4 IN 1 DAY, ORAL | 1 0.01 90.55 50 MG, 4 TIMES DAILY, ORAL | 1 0.01 90.56 50 MG, BID | 1 0.01 90.57 50 MG, BID, ORAL | 1 0.01 90.58 50 MG, DAILY | 1 0.01 90.59 50 MG, DAILY, ORAL | 5 0.05 90.64 50 MG, ORAL | 1 0.01 90.65 50 MG, QD | 3 0.03 90.68 50 MG, QHS | 1 0.01 90.69 50 MG, QHS, ORAL | 1 0.01 90.70 50 MG, TID | 3 0.03 90.73 50 MG, UNK | 1 0.01 90.74 50 MG/D | 1 0.01 90.75 50 MG/DAILY PO | 2 0.02 90.77 50 MG/DAY | 1 0.01 90.78 50 MG/M2 DAILY ORAL | 2 0.02 90.80 50 MG; EVERY OTHER WEEK; INTRATHECAL | 1 0.01 90.81 50 QD ORAL | 1 0.01 90.82 50 UG/HR, 1 IN 72 HOUR, TRANSDERMAL :.. | 1 0.01 90.83 50 UNITS Q8H IV | 1 0.01 90.84 50-75 MG IV Q 3-4 H PRN | 1 0.01 90.85 50.4 GR 28 FR | 2 0.02 90.87 50.4 GY | 1 0.01 90.88 50/200 MG, 3 TABLETS DLY | 1 0.01 90.89 500 MCG, BID, ORAL | 1 0.01 90.90 500 MG | 1 0.01 90.91 500 MG , PO | 1 0.01 90.92 500 MG /D PO | 1 0.01 90.93 500 MG 2/D PO | 2 0.02 90.95 500 MG BID ORALLY | 1 0.01 90.96 500 MG DAILY ORAL | 1 0.01 90.97 500 MG DAILY PO | 4 0.04 91.01 500 MG IV QD | 1 0.01 91.02 500 MG ONCE PER D ORAL | 1 0.01 91.03 500 MG PO | 1 0.01 91.04 500 MG PO BID | 2 0.02 91.06 500 MG PRN PO | 1 0.01 91.07 500 MG Q 8H ORAL | 1 0.01 91.08 500 MG QD | 1 0.01 91.09 500 MG QID PO | 1 0.01 91.10 500 MG TWICE DAIL ORAL | 1 0.01 91.11 500 MG, 1 IN 1 D, PER ORAL | 1 0.01 91.12 500 MG, 1 IN 1 DAY, ORAL | 1 0.01 91.13 500 MG, BID | 1 0.01 91.14 500 MG, PER ORAL | 1 0.01 91.15 500 MG, PO | 2 0.02 91.17 500 MG, QD, | 1 0.01 91.18 500 MG/400 MG , PO | 1 0.01 91.19 500 MG/D | 2 0.02 91.21 500 MG/DAY | 1 0.01 91.22 500 MG/M2, WEEKLY FOR FOUR WEEKS, INT.. | 2 0.02 91.24 500 MG/M2, WEEKLY FOR FOUR WEEKS,INTR.. | 1 0.01 91.25 5000 IU, BID | 1 0.01 91.26 5000 IU, BID, SUBCUTANEOUS | 1 0.01 91.27 5000 U, 3 IN 1 WEEKS | 1 0.01 91.28 500MG FOUR TIMES PER DAY | 1 0.01 91.29 500MG PER DAY | 2 0.02 91.31 500MG QD ORAL | 1 0.01 91.32 500MG THREE TIMES PER DAY | 1 0.01 91.33 500MG TWICE PER DAY | 5 0.05 91.38 500MG/DAY | 1 0.01 91.39 500~1500 MG/DAY | 1 0.01 91.40 50MCG PER DAY | 2 0.02 91.42 50MCG TWICE PER DAY | 3 0.03 91.45 50MCG VARIABLE DOSE | 1 0.01 91.46 50MG PER DAY | 1 0.01 91.47 50MG TWICE DAIL ORAL | 1 0.01 91.48 530 MG; Q3W; INTRAVENOUS | 1 0.01 91.49 54 MG, 1 IN 1 DAY, ORAL | 1 0.01 91.50 54 MG, IN 1 DAY | 1 0.01 91.51 54 MG, IN 1 DAY, ORAL | 1 0.01 91.52 560 MG, TID; 480 MG, TID | 1 0.01 91.53 565 MG | 1 0.01 91.54 57 MG D1 IV | 1 0.01 91.55 590 MG IN HER BODY | 1 0.01 91.56 5MCG/KG/MIN INHALATION | 1 0.01 91.57 5MG BID ORAL | 1 0.01 91.58 5MG DAILY ORAL | 1 0.01 91.59 5MG PER DAY | 5 0.05 91.64 5MG QD ORAL | 1 0.01 91.65 5MG/KG OVER 30-90 MINUTES IV INFUSION.. | 1 0.01 91.66 5ML, INTRAVENOUS | 1 0.01 91.67 6 G (EVERY 4 HOURS) | 1 0.01 91.68 6 GRAM (BID), INTRAVENOUS | 1 0.01 91.69 6 MG 1 X PER 1 DAY, ORAL | 1 0.01 91.70 6 MG 1X PER 1 WK, ORAL | 2 0.02 91.72 6 MG DAILY ORAL | 1 0.01 91.73 6 MG, BID | 10 0.10 91.83 6 MG, IN 1 DAY, ORAL | 1 0.01 91.84 6 MG, IN 1 WEEK, ORAL | 1 0.01 91.85 6 MG, Q21, DAYS, CYCLIC, SUBCUTANEOUS | 1 0.01 91.86 6 MG, QD | 3 0.03 91.89 6 MG, UNK | 3 0.03 91.92 6 MG/4 MG 2X/5X WEEKS ORAL | 1 0.01 91.93 6 MIU QD INTRAMUSCULAR | 1 0.01 91.94 6 MIU QD INTRAMUSCULAR; 6 MIU TIW INT.. | 1 0.01 91.95 6 MU 6X/WK INTRAMUSCULAR | 1 0.01 91.96 6 MU INTRAMUSCULAR | 4 0.04 92.00 6 MU TIW INTRAMUSCULAR | 1 0.01 92.01 6 MU TIW-BIW* INTRAMUSCU | 1 0.01 92.02 6 UNITS/KG/HOUR | 1 0.01 92.03 6-8 MG IV Q 3-4 H PRN | 1 0.01 92.04 6.75 GRAM (Q8H), INTRAVENOUS | 1 0.01 92.05 60 MG 1X PER 1 DAY | 1 0.01 92.06 60 MG IV | 1 0.01 92.07 60 MG QD PO | 1 0.01 92.08 60 MG QDAY PO | 4 0.04 92.12 60 MG, BID | 1 0.01 92.13 60 MG/D | 1 0.01 92.14 60 MG/KG X 2 | 1 0.01 92.15 60 MG/M2 PER CYCLE | 1 0.01 92.16 60 MG/M2 PER_CYCLE | 1 0.01 92.17 60 ML 1X EPIDURAL | 1 0.01 92.18 60 ML/D | 1 0.01 92.19 60 UNITS, AT BEDTI | 1 0.01 92.20 600 MG | 1 0.01 92.21 600 MG (BID), ORAL | 1 0.01 92.22 600 MG (UNKNOWN); ORAL (SEE IMAGE) | 1 0.01 92.23 600 MG BID ORAL | 1 0.01 92.24 600 MG DAILY | 1 0.01 92.25 600 MG IV Q 12 HOURS | 1 0.01 92.26 600 MG QD ORAL | 2 0.02 92.28 600 MG TWICE A DAY ORAL | 1 0.01 92.29 600 MG, 1 IN 1 D, PER ORAL | 1 0.01 92.30 600 MG, BID, IV | 1 0.01 92.31 600 MG, HS | 1 0.01 92.32 600 MG, TID | 1 0.01 92.33 600 MG/D | 4 0.04 92.37 600 MG/DAY | 1 0.01 92.38 600 MG/M2 PER CYCLE | 2 0.02 92.40 60000 U, 1 IN 1 WEEKS, SC | 1 0.01 92.41 60000 U, WEEKLY, SC | 2 0.02 92.43 60MG UNKNOWN | 1 0.01 92.44 60U TWICE PER DAY | 1 0.01 92.45 62 MG, UNK, IV DRIP | 1 0.01 92.46 62.5 MG, BID, ORAL | 1 0.01 92.47 62.5 MG, BID; 125 MG, BID; 62.5 MG | 1 0.01 92.48 62.5 MG, QD, ORAL | 1 0.01 92.49 64 MG IV WEEKLY | 3 0.03 92.52 65 MG/M2 EVERY 3 WE IV | 1 0.01 92.53 650 MG QD | 1 0.01 92.54 660MCG PER DAY | 1 0.01 92.55 69 MG DAY 1 IV | 1 0.01 92.56 6CAP PER DAY | 1 0.01 92.57 6MG PO ORAL | 1 0.01 92.58 6MG, 6MG QHS, ORAL | 1 0.01 92.59 7.5 G DAILY | 1 0.01 92.60 7.5 G NIGHTLY PO | 1 0.01 92.61 7.5 G, UNK, ORAL | 1 0.01 92.62 7.5 MG 1X PER 1 WK, ORAL | 1 0.01 92.63 7.5 MG AES#DOSE_FREQUENCY: DLY | 1 0.01 92.64 7.5 MG DAILY PO | 2 0.02 92.66 7.5 MG WEEKLY/5 MG WEEKLY/2.5 MG WEEKLY | 1 0.01 92.67 7.5 MG, IN 1 WEEK | 1 0.01 92.68 7.5 MG, UNK | 1 0.01 92.69 7.5 MG/KG (D1-Q3W) OVER 30-90 MINUTES.. | 1 0.01 92.70 7.5 ML, IN 1 DAY, ORAL | 1 0.01 92.71 7.5 WEEK PO | 1 0.01 92.72 7.5MG CUMULATIVE DOSE | 1 0.01 92.73 7.5MG UNKNOWN | 1 0.01 92.74 7.8 MG, 3 IN 1 DAY | 1 0.01 92.75 70 MG/M2 IV | 1 0.01 92.76 70 MG/M3 | 1 0.01 92.77 700 MG, QD, IV | 1 0.01 92.78 700MG PER DAY | 1 0.01 92.79 72 MG IV | 1 0.01 92.80 74 MG , ON DAY 5, IV | 1 0.01 92.81 75 - 600 MG/DAY | 1 0.01 92.82 75 MCG, 1 IN 1 D, PER ORAL | 1 0.01 92.83 75 MG (NR), PO | 1 0.01 92.84 75 MG 1X PER 1 DAY | 1 0.01 92.85 75 MG 1X PER 1 DAY ORAL | 1 0.01 92.86 75 MG BID | 1 0.01 92.87 75 MG BID PO | 1 0.01 92.88 75 MG HS ORAL | 1 0.01 92.89 75 MG OD | 1 0.01 92.90 75 MG PO | 1 0.01 92.91 75 MG PO QD | 1 0.01 92.92 75 MG Q 4H PRN INTRAVENOUS | 1 0.01 92.93 75 MG QD - ORAL | 1 0.01 92.94 75 MG QD PO | 2 0.02 92.96 75 MG TID | 1 0.01 92.97 75 MG, 500 MG/400 MG , PO | 1 0.01 92.98 75 MG, BID | 2 0.02 93.00 75 MG, PO | 3 0.03 93.03 75 MG, UNK | 1 0.01 93.04 75 MG/DAY ORAL | 1 0.01 93.05 75 MG/M2 IV Q WK X 6 | 1 0.01 93.06 75 MG/M2 PO | 1 0.01 93.07 75 UG/HR, 1 IN 72 HOUR, TRANSDERMAL | 3 0.03 93.10 75 UG/HR, TRANSDERMAL | 1 0.01 93.11 75-200MG QD ORAL | 1 0.01 93.12 750 MG IV | 1 0.01 93.13 750 MG QD ORAL | 1 0.01 93.14 750 MG, QD | 1 0.01 93.15 75MG AT NIGHT | 1 0.01 93.16 75MG PER DAY | 1 0.01 93.17 75MG THREE TIMES PER DAY | 1 0.01 93.18 75MG/DAY | 1 0.01 93.19 75UG/DAY | 1 0.01 93.20 760 MG FREQ | 1 0.01 93.21 773 MG; Q3W; INTRAVENOUS | 1 0.01 93.22 78 MG, 1 IN 1 DAY, INTRAVENOUS | 1 0.01 93.23 78.5 MG | 1 0.01 93.24 78.5 MG IV | 1 0.01 93.25 79.2 MG | 1 0.01 93.26 79.2 MG IV | 1 0.01 93.27 8 CAPSULE, 1 IN 1 D, PER ORAL | 1 0.01 93.28 8 MG (1 MG, 2 QID); PO (SEE IMAGE) | 1 0.01 93.29 8 MG 1X PER 1 DAY; 7 MG 1X PER 1 DAY | 1 0.01 93.30 8 MG ONCE ED | 1 0.01 93.31 8 MG, 12H + 1 H BEFORE CHEMO, ORAL; .. | 1 0.01 93.32 8 MG, IN 1 DAY, ORAL;16 MG, IN 1 DAY,.. | 1 0.01 93.33 8 MG, INTRAVENOUS | 2 0.02 93.35 8 MIU, EVERY 2 D, SUBCUTANEOUS | 2 0.02 93.37 8 MIU, EVERY 2D, SUBCUTANEOUS | 6 0.06 93.43 8 MIU, SUBCUTANEOUS | 1 0.01 93.44 80 MG (DAILY), ORAL | 1 0.01 93.45 80 MG /.M2 IV (150 MG) | 1 0.01 93.46 80 MG /M2 Q 3 WKS X 4 | 1 0.01 93.47 80 MG /M2 Q3 WKS X 4 | 1 0.01 93.48 80 MG AM 40 AM 40 PM ORAL | 1 0.01 93.49 80 MG PO | 2 0.02 93.51 80 MG PO DAILY | 1 0.01 93.52 80 MG PRN PO | 1 0.01 93.53 80 MG QD ORAL | 3 0.03 93.56 80 MG, 1/WEEK, INTRAVENOUS | 1 0.01 93.57 80 MG, BID | 2 0.02 93.59 80 MG, PER ORAL | 1 0.01 93.60 80 MG, Q8H, ORAL | 1 0.01 93.61 80 MG, QD | 4 0.04 93.65 80 MG, TOTAL DAILY, ORAL | 1 0.01 93.66 80 MG, UNK | 1 0.01 93.67 80 MG, UNK, UNK | 1 0.01 93.68 80 MG/DAY | 3 0.03 93.71 80 MG/M2 CONT - INTRAVENOUS NOS | 1 0.01 93.72 80 MG/M2 Q 3 WKS | 1 0.01 93.73 80 MG/M2 Q 3 WKS X 4 | 1 0.01 93.74 80/12.5 | 1 0.01 93.75 80/12.5 MG | 1 0.01 93.76 80/12.5 MG ORAL | 1 0.01 93.77 800 MCG, VAGINAL | 1 0.01 93.78 800 MG (DAILY), ORAL | 2 0.02 93.80 800 MG ORAL | 4 0.04 93.84 800 MG QD ORAL | 5 0.05 93.89 800 MG, 1 IN 1 D, PER ORAL | 1 0.01 93.90 800 MG, PER ORAL | 1 0.01 93.91 800 MG, QD | 1 0.01 93.92 800 MG, UNK | 1 0.01 93.93 800 MG/DAY | 1 0.01 93.94 800 MG/M2 DAILY PO | 1 0.01 93.95 80000 U, 3 IN 1 WEEKS, IV | 1 0.01 93.96 80MG PER DAY | 1 0.01 93.97 80MGM2 PER DAY | 1 0.01 93.98 81 MG, 1 IN 1 DAY, ORAL | 1 0.01 93.99 81 MG, UNK | 2 0.02 94.01 810 MG | 1 0.01 94.02 81MG ALTERNATE DAYS | 1 0.01 94.03 81MG PER DAY | 2 0.02 94.05 845 MG ONCE WEEKLY X 4 WEEKS, INTRAVE.. | 1 0.01 94.06 85 MG/M2 Q2W; INTRAVENOUS NOS | 3 0.03 94.09 850 MG/M2 TWICE DAILY FROM D1 TO D15,.. | 1 0.01 94.10 87 ML, 1 DOSE, INTRAVENOUS | 1 0.01 94.11 880MCG TWICE PER DAY | 1 0.01 94.12 88MCG AT NIGHT | 1 0.01 94.13 88MCG PER DAY | 1 0.01 94.14 88MCG TWICE PER DAY | 6 0.06 94.20 88MCG VARIABLE DOSE | 1 0.01 94.21 88MG/92MG 3 PER DAY INTRAVENOUS | 1 0.01 94.22 8MG PER DAY | 1 0.01 94.23 8MG TWICE PER DAY | 1 0.01 94.24 9 G/M2 PER_CYCLE | 1 0.01 94.25 90 MG BID SUB | 1 0.01 94.26 90 MG PER MONTH | 1 0.01 94.27 90 MG, CYCLIC, IV DRIP | 1 0.01 94.28 90 MG, CYCLIC, IV DRIP; 130 MG, CYCLI.. | 1 0.01 94.29 90 MG, EVERY 28 DAYS | 1 0.01 94.30 90 MG, ONCE/SINGLE | 2 0.02 94.32 90 MG, QD, IV | 1 0.01 94.33 90 MG, QMO | 1 0.01 94.34 90 MG/DAY | 1 0.01 94.35 90 MG/M2 QWKX 3 /CYCL IV | 1 0.01 94.36 900 MG 1/D | 1 0.01 94.37 900 MG 4/D PO | 1 0.01 94.38 900 MG DAILY | 1 0.01 94.39 900 MG/M2, Q21 DAYS, CYCLIC, IV | 1 0.01 94.40 900MG PER DAY | 2 0.02 94.42 91 MG Q21D IV | 1 0.01 94.43 92 UNITS PRN IM | 1 0.01 94.44 980 MCG/HR CONTINUOUS IV | 1 0.01 94.45 ACTUAL DOSE GIVEN 257MG, ONCE EVERY .. | 1 0.01 94.46 ACTUAL DOSE GIVEN = 2000MG TWICE A DA.. | 1 0.01 94.47 ADMINISTERED FOR MORE THAN ONE YEAR. | 1 0.01 94.48 AUC 5 | 1 0.01 94.49 AUC 6 IV (558 MG) | 1 0.01 94.50 AUC 6 Q 3 WKS | 1 0.01 94.51 BEGAN 75 MG QD (ON A FEW YRS),DOSE IN.. | 1 0.01 94.52 BETWEEN 100 - 300 MG/DAY | 1 0.01 94.53 BID | 1 0.01 94.54 BID PO | 1 0.01 94.55 BID, ORAL | 1 0.01 94.56 BID, TOPICAL | 2 0.02 94.58 BOLUS DOSE; INTRAVENOUS | 1 0.01 94.59 BUCCAL | 1 0.01 94.60 CARBOPLATIN GIVEN AT 3RD CYCLE -22DEC03 | 1 0.01 94.61 CODE NOT BROKEN | 1 0.01 94.62 CYCLE 3 - 22DEC03, DOSE REDUCED 20% | 1 0.01 94.63 CYCLIC | 2 0.02 94.65 CYNT 0.3. DOSE REPORTED AS 1-0-0-1. | 1 0.01 94.66 CYTARABINE 1500MG/M2 INTRAVENOUS | 1 0.01 94.67 D1 AND D8 | 1 0.01 94.68 D1 TO D5 | 1 0.01 94.69 DAILY INJECTION | 1 0.01 94.70 DAILY ORAL | 2 0.02 94.72 DAILY, INTRATHECAL | 1 0.01 94.73 DAY 4 | 1 0.01 94.74 DISCONTINUED 18-DEC-03 | 1 0.01 94.75 DISCONTINUED FROM STUDY 18-DEC-03 | 1 0.01 94.76 DOSAGE INCREASED | 2 0.02 94.78 DOSAGE REDUCED | 2 0.02 94.80 DOSAGE REGIMEN PROVIDED AS '1MG 1 - 6'. | 1 0.01 94.81 DOSAGE UNSPECIFIED, GRADUALLY INCREAS.. | 1 0.01 94.82 DOSE = AUC 6 | 1 0.01 94.83 DOSE REDUCED TO 50 MG | 1 0.01 94.84 DOSE REPORTED AS 1-0-0-1/2. | 1 0.01 94.85 DOSE REPORTED AS 1-0-1. | 1 0.01 94.86 DOSE REPORTED AS 2 X 100. | 1 0.01 94.87 DOSE REPORTED AS 6 X 200. | 1 0.01 94.88 DOSE UNIT: UNITS | 9 0.09 94.97 DOSE ^PERIODICALLY THROUGHOUT ADULTHO.. | 1 0.01 94.98 DOSE: 1 DOSE | 1 0.01 94.99 DOSE: 114-115 | 1 0.01 95.00 DOSE: 12/10/11; DOSE UNIT: UNITS | 1 0.01 95.01 DOSE: 160/12.5 | 1 0.01 95.02 DOSE: 3 TABLETS | 1 0.01 95.03 DOSE: 3T | 1 0.01 95.04 DOSE: 4MG/WEEK | 1 0.01 95.05 DOSE: 6T | 1 0.01 95.06 DOSE: 750-775 | 1 0.01 95.07 DOSE: 8/500 | 1 0.01 95.08 DOSE: NOT PROVIDED | 1 0.01 95.09 DOSE: ONE SPRAY | 1 0.01 95.10 DOSE: PRN | 1 0.01 95.11 DOSE: UNK | 20 0.20 95.31 DOSE: UNK GIVEN PARENTERALLY | 1 0.01 95.32 DOSE: UNKNOWN | 3 0.03 95.35 DP | 1 0.01 95.36 DRUG NAME REPORTED AS METHISTA. | 1 0.01 95.37 DRUG REPORTED AS 7DERMATRANS, FORMULA.. | 1 0.01 95.38 DS BID PO | 1 0.01 95.39 EVERY 2D, SUBCUTANEOUS | 1 0.01 95.40 EVERY 6 WE INTRAVENOUS | 1 0.01 95.41 EVERY DAY ONCE A DAY | 1 0.01 95.42 EVERY NIGHT | 1 0.01 95.43 EVERYDAY ONCE Q DAY | 1 0.01 95.44 FIRST CYCLE ADMINISTRATION 21-NOV-200.. | 1 0.01 95.45 FIRST CYCLE ADMINISTRATION ON 21-NOV-.. | 1 0.01 95.46 FIRST INFUSION OF STUDY MEDICATION 17.. | 1 0.01 95.47 FIRST INFUSION: 17-FEB-03. DISCONTIN.. | 1 0.01 95.48 FOR 4 DOSES | 1 0.01 95.49 FOR YEARS | 1 0.01 95.50 FORM REPORTED AS PACK. DRUG NAME REPO.. | 1 0.01 95.51 FORMULATION REPORTED AS INJECTABLE SO.. | 1 0.01 95.52 FROM DAY -1 | 2 0.02 95.54 G/M2 WEEKLY | 1 0.01 95.55 GIVEN AFTER ONSET OF SYMPTOMS | 1 0.01 95.56 GIVEN DAYS ONE TO FOURTEEN IN A TWENT.. | 1 0.01 95.57 GIVEN ON DAY ONE OF A TWENTY ONE DAY .. | 1 0.01 95.58 GIVEN ON DAYS 1 AND 22 OF A 6 WEEK CY.. | 1 0.01 95.59 GM IV | 1 0.01 95.60 HOME DOSE | 2 0.02 95.62 IMATINIB 400 MG PO QD | 1 0.01 95.63 IN AM FOR YEARS | 1 0.01 95.64 INFUSION; INTRAVENOUS | 1 0.01 95.65 INHALATION | 2 0.02 95.67 INITIATED AT 10 MG/DAY | 1 0.01 95.68 INT CORP CAVERN | 2 0.02 95.70 INTAVENOUS | 1 0.01 95.71 INTERMITTENT THERAPY OF THREE WEEKS T.. | 1 0.01 95.72 INTERRUPTED ON 25-OCT-2002 AND RESTAR.. | 2 0.02 95.74 INTRA-ARTERIAL | 1 0.01 95.75 INTRADERMAL | 1 0.01 95.76 INTRAMUSCULAR | 2 0.02 95.78 INTRAUTERINE | 2 0.02 95.80 INTRAUTERINE EXPOSURE | 4 0.04 95.84 INTRAVENOUS | 23 0.23 96.07 INTRAVENOUS DRIP | 2 0.02 96.09 INTRVENOUS | 1 0.01 96.10 IU, SUBCUTANEOUS | 1 0.01 96.11 IV | 8 0.08 96.19 LAMIVUDINE 150 MG + ZIDOVUDINE 300 MG.. | 1 0.01 96.20 LEVO 100 / BENZ 25 MG/DAY | 1 0.01 96.21 LEVO 100 / BENZ 25/QID | 1 0.01 96.22 LOADING DOSE | 1 0.01 96.23 LOADING DOSE 04-APR-2003-DOSE 400MG/M.. | 1 0.01 96.24 LOADING DOSE 400 MG/M2 ON 12-JAN-04 | 2 0.02 96.26 MAX 4X /MONTH FOR 1-2 DAYS | 1 0.01 96.27 MAXIMUM 8 CYCLES | 1 0.01 96.28 MAXIMUM OF 8 CYCLES | 1 0.01 96.29 MCG, DAILY, INTRATHECAL | 1 0.01 96.30 MG (MG, 1 TA/DAY) | 1 0.01 96.31 MOST RECENT DOSE PRIOR TO EVENT 02-DE.. | 2 0.02 96.33 MOTHER RECEIVED INFUSION AT DELIVERY .. | 1 0.01 96.34 MULTIPLE THERAPIES. ONE DOSING REGIME.. | 1 0.01 96.35 NAS | 1 0.01 96.36 NASAL | 1 0.01 96.37 NEUPOGEN 480MCG SUBCUTANEOUS | 1 0.01 96.38 NI TRP | 1 0.01 96.39 NO TREATMENT RECEIVED | 1 0.01 96.40 NORMAL DOSES PO | 1 0.01 96.41 NOT REPORTED | 1 0.01 96.42 NR (NR), NR | 1 0.01 96.43 NR (NR); NR | 1 0.01 96.44 OHPTHALMIC | 1 0.01 96.45 ON DAYS 1 TO 15 AND DAYS 22 TO 36 FOR.. | 1 0.01 96.46 ON DAYS ONE AND TWENTY TWO BEFORE IRI.. | 1 0.01 96.47 ON FOR 8 YEARS, 30 WKS 4 DAYS,TIME TO.. | 1 0.01 96.48 ON RX IN THE ^LAST FEW YEARS^. WAS KE.. | 1 0.01 96.49 ON THERAPY FOR OVER 10 YEARS | 1 0.01 96.50 ONCE | 1 0.01 96.51 ONCE A DAY | 2 0.02 96.53 ONCE DAY ORAL | 1 0.01 96.54 ONCE QD PO | 2 0.02 96.56 ONE DOSE | 1 0.01 96.57 ONE DOSE PO QD | 1 0.01 96.58 ONE INHALATION BID | 1 0.01 96.59 ONE PATCH Q 8 HRS., TOPICAL | 1 0.01 96.60 ONE PO DAILY | 1 0.01 96.61 ONE TABLET ONCE DAILY ORAL | 1 0.01 96.62 OPHT | 1 0.01 96.63 OPHTHALMIC | 1 0.01 96.64 ORAL | 110 1.10 97.74 OVERALL TREATMENT DURATION WITH PEG-I.. | 1 0.01 97.75 PER INDUCTION COG # 9900 | 1 0.01 97.76 PER INDUCTION COG #9900 | 4 0.04 97.80 PER ORAL | 5 0.05 97.85 PER ORAL ; 1000 MG, 1 IN 1 D, PER ORAL | 1 0.01 97.86 PO | 12 0.12 97.98 PO 5 MG DAILY X 7 DAYS, 5 MG BID X 7 .. | 1 0.01 97.99 PO PRN | 1 0.01 98.00 PO X 1 DOSE | 1 0.01 98.01 PO, X 2 DOSES | 1 0.01 98.02 PO; 2.25 MG (0.25 MG, 3 IN 1 D); 3 MG.. | 1 0.01 98.03 PRN, ORAL | 2 0.02 98.05 Q 72 HOURS TRANSDERMAL | 1 0.01 98.06 Q3W; INTRAVENOUS | 2 0.02 98.08 QD PO 21D/MONTH | 1 0.01 98.09 QD, INTRAVENOUS | 3 0.03 98.12 QD, ORAL | 1 0.01 98.13 REPORTED AS GASTER D. | 1 0.01 98.14 ROUTE IV CENTRAL LINE 74 MG 1MG/MIN | 1 0.01 98.15 ROUTE REPORTED AS DRIP. | 1 0.01 98.16 ROUTE, DOSE AND FREQUENCY BLINDED. | 2 0.02 98.18 SECOND INDICATION REPORTED AS CORONAR.. | 1 0.01 98.19 SEE IMAGE | 38 0.38 98.57 SEE IMAGE INTRAVENOUS | 1 0.01 98.58 SEE IMAGE ORAL | 4 0.04 98.62 SEE IMAGE SUBCUTANEOUS | 1 0.01 98.63 SEE IMAGE, PER ORAL | 1 0.01 98.64 SEE IMAGE, ORAL | 1 0.01 98.65 SEE IMAGE; 2-3 TIMES PER DAY | 1 0.01 98.66 SHORT-TERM THERAPY | 1 0.01 98.67 SPORADICALLY FOR SOME YEARS | 1 0.01 98.68 SPRAY 1X EA NOS NASAL | 1 0.01 98.69 STANDARD DOSE 3 CAP QD PO | 1 0.01 98.70 STARTED DOSING ABOUT 3 MONTHS AGO | 1 0.01 98.71 STOPPED JAN-2003, RESTARTED 12-JAN-2004 | 3 0.03 98.74 STOPPED ON 17 SEP 2003 AND RESTARTED .. | 1 0.01 98.75 SUBCUTANEOUS | 4 0.04 98.79 SUBLINGUAL | 1 0.01 98.80 SURGICAL SCR | 1 0.01 98.81 SY | 1 0.01 98.82 SYMPTOMS OCCURRED AFTER THE SECOND AD.. | 1 0.01 98.83 TABLETS | 1 0.01 98.84 TAKEN EVERY WEEK | 1 0.01 98.85 TAKEN WEEKLY | 1 0.01 98.86 TAXOL 175 MG/M^2 FROM 18-JUN TO 09-JU.. | 1 0.01 98.87 TAXOTERE 60MG/M2 | 1 0.01 98.88 TDD REPORTED AS 2 PER DAY. | 1 0.01 98.89 TDD REPORTED AS 200. | 1 0.01 98.90 THERAPY DATES: 07-FEB-2002 TO 21-NOV-.. | 1 0.01 98.91 THERAPY DATES: 07-FEB-2002 TO 28-JUN-.. | 2 0.02 98.93 THERAPY DATES: 17-FEB-2004 TO 02-MAR-.. | 1 0.01 98.94 THERAPY DATES: AUG-1999 TO NOV-1999 | 1 0.01 98.95 THERAPY INITIATED 29-JAN-2004-PT RECE.. | 2 0.02 98.97 THERAPY THROUGH ENTIRE GESTATION | 3 0.03 99.00 TID 3.75 MG | 1 0.01 99.01 TIME TO ONSET 4 YRS 25 WEEKS 2 DAYS | 1 0.01 99.02 TIME TO ONSET: 4 YRS 25 WEEKS 2 DAYS | 1 0.01 99.03 TIW SUBCUTANEOUS | 3 0.03 99.06 TO PUFFS Q 4 HRS FOR WHEEZING | 1 0.01 99.07 TOPICAL | 2 0.02 99.09 TOTAL DOSE 200 MG: INTRAVENOUS (NOT O.. | 1 0.01 99.10 TRADE NAME REPORTED AS OCTEGRA. | 1 0.01 99.11 TRADE NAME: LINOLA FETT SALLE. TAKEN .. | 1 0.01 99.12 TRADE NAME: TOWATHIEM (NON-PYRINE PRE.. | 1 0.01 99.13 TRADENAME REPORTED AS ROVALCYTE. | 1 0.01 99.14 TRANSDERMAL | 7 0.07 99.21 TRANSDERMAL ; 75 UG/HR, TRANSDERMAL | 1 0.01 99.22 TWICE DAILY | 2 0.02 99.24 TWICE DAILY MOUTH [LIFE -3 YRS SO FAR] | 1 0.01 99.25 TWICE DAILY ON DAYS 1-15 EVERY 21 DAYS. | 1 0.01 99.26 TYPE 2 DM | 1 0.01 99.27 UD QD ORAL | 1 0.01 99.28 UNK | 10 0.10 99.38 UNK, BID | 1 0.01 99.39 UNK, BID, ORAL | 1 0.01 99.40 UNK, MG, UNK; ORAL ( SEE IMAGE) | 1 0.01 99.41 UNK, ONCE/SINGLE | 1 0.01 99.42 UNK, ORAL | 3 0.03 99.45 UNK, PRN | 3 0.03 99.48 UNK, TID | 1 0.01 99.49 UNK, UNK | 9 0.09 99.58 UNK, UNK, INT CORP CAVERN | 3 0.03 99.61 UNK., 1 IN 1 D, PER ORAL; 30 MG, 1 I.. | 1 0.01 99.62 UNKNOWN | 5 0.05 99.67 UNKNOWN; ORAL | 8 0.08 99.75 UNSPECIFIED | 1 0.01 99.76 UNSPECIFIED; ORAL | 2 0.02 99.78 USED AS DIRECTED ON PRODUCT LABELING | 1 0.01 99.79 VAL 80 / HCT 12.5 MG/DAY | 1 0.01 99.80 VALS 80 / HCT 12.5 MG/DAY | 2 0.02 99.82 VAR Q DAY PO | 2 0.02 99.84 VARIOUS, 4MG QD, , ORAL | 1 0.01 99.85 VARYING DOSES | 1 0.01 99.86 VERY INFREQUENT | 1 0.01 99.87 VESDIL 2.5 DOSE REPORTED AS 1-0-1. | 1 0.01 99.88 ^100^ MG QD ORAL | 1 0.01 99.89 ^2 A DAY^, ORAL | 1 0.01 99.90 ^2 TBSP ONCE OR TWICE DAILY^ | 1 0.01 99.91 ^3 WEEK OF PREMARIN AND ONE WEEK PROV.. | 1 0.01 99.92 ^3.0^ TIW, SUBCUTANEOUS, ^1.5^ TIW, S.. | 1 0.01 99.93 ^667 MG ONCE A DAY BEFORE MEALS + MAY.. | 1 0.01 99.94 ^AT BEDTIME^ | 1 0.01 99.95 ^FOR SEVERAL YEARS^, ORAL | 1 0.01 99.96 ^ONCE EVERY DAY OR 4 TIMES A DAY^ (UN.. | 1 0.01 99.97 ^RECOMMENDED DOSE FOR 2 DAYS^, ORAL | 1 0.01 99.98 ^SEVERAL CYCLES^ | 1 0.01 99.99 { 1 ML QD TO BID, TOPICAL | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015